US20070017870A1 - Multicapillary device for sample preparation - Google Patents
Multicapillary device for sample preparation Download PDFInfo
- Publication number
- US20070017870A1 US20070017870A1 US11/524,426 US52442606A US2007017870A1 US 20070017870 A1 US20070017870 A1 US 20070017870A1 US 52442606 A US52442606 A US 52442606A US 2007017870 A1 US2007017870 A1 US 2007017870A1
- Authority
- US
- United States
- Prior art keywords
- sample preparation
- multicapillary
- preparation device
- sample
- stationary phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/50—Conditioning of the sorbent material or stationary liquid
- G01N30/56—Packing methods or coating methods
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/60—Construction of the column
- G01N30/6034—Construction of the column joining multiple columns
- G01N30/6043—Construction of the column joining multiple columns in parallel
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/50—Conditioning of the sorbent material or stationary liquid
- G01N30/56—Packing methods or coating methods
- G01N2030/567—Packing methods or coating methods coating
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/60—Construction of the column
- G01N30/6052—Construction of the column body
- G01N30/6073—Construction of the column body in open tubular form
- G01N30/6078—Capillaries
Definitions
- the present invention relates to a multicapillary sample preparation device especially useful for handling biological samples.
- the multicapillary device is suitable for use with a pipette, micropipette, syringe, or other similar analytical instrument.
- MALDI-MS matrix assisted laser desorption/ionization mass spectrometry
- pipettes To handle samples in the 0.01 to 100 microgram ( ⁇ g) range, pipettes, micropipettes, syringes or similar analytical instruments (collectively referred to hereinafter as “pipettes”) are commonly employed.
- the tip of these pipettes is fitted with one or more adsorptive or membranous plugs capable of purifying, concentrating, or fractionating peptides and other biomolecules.
- porous materials are generally not effective at separating smaller biomolecules such as proteins and polynucleotides. Porous plugs are also deficient with respect to isolating and purifying larger biological materials and nucleic acids such as DNA, RNA and cells. This shortcoming derives from the fact that during sample processing, molecules must wend through a labyrinth of sponge-like, expansive and porous adsorbent silica.
- an object of the present invention to provide an efficient sample preparation device for use in isolating (immunoassay), purifying and concentrating samples of proteins, peptides, nucleic acids (e.g., DNA and RNA), and other biological materials (e.g., cells) prior to analysis.
- isolating immunoassay
- nucleic acids e.g., DNA and RNA
- other biological materials e.g., cells
- the invention is a high surface area multicapillary sample preparation device especially useful for handling biological samples.
- the multicapillary device does not require use of a silica type porous substrate. Rather, the device incorporates a plurality of parallel capillary tubes, wherein the cavity of each tube remains open and unobstructed throughout sample processing.
- the capillary tubes of the device function independently of one another so that sample molecules are incapable of being physically exchanged or diffusing from one capillary to another.
- the multicapillary device is preferably disposed in a housing that is suitable for attachment to a “pipette” or other sample preparation or analytical instrument, enabling the isolation, purification, concentration and/or fractionation of nucleic acids or biological samples in the micro- and nanoliter range, as well as larger mass loads and volumes.
- the multicapillary device features a monolithic element pierced with multiple uniform capillaries.
- the monolithic element is typically mounted in the lower end of a pipette tip, syringe needle or tubing, and is operated using a pipette.
- an insoluble stationary phase material is deposited onto the interior surfaces (walls) of each capillary tube, without employing a supporting or intermediary constituent.
- the invention also includes a method of preparing a multicapillary device for protein sample preparation.
- inner walls of the capillary tubes are first coated with a stationary phase material, and then the monolithic element is mounted in an appropriate housing.
- the monolithic element can first be fixed in a housing, after which the capillary walls can be coated with the stationary phase.
- the multicapillary sample preparation device is attached to a pipette, micropipette, tube, syringe or similar analytical instrument.
- FIG. 1 is a perspective view of a multicapillary device for sample preparation in accordance with an embodiment of the present invention. Individual capillaries of the device are shown in the enlarged, cross-sectional views of FIGS. 2A, 2C and 2 D (SEM).
- FIG. 2B is an exploded, perspective view of an individual capillary tube.
- FIG. 3 depicts SEM images showing cross-sectional views of a conventional sample preparation device.
- FIGS. 4A-4D are perspective views of pipette tips and a pipette format multicapillary device, respectively, in accordance with the present invention.
- FIGS. 5A-5C show perspective views of a syringe format multicapillary device for sample preparation according to the present invention.
- FIG. 6 is a chromatogram showing the separation of a three component mixture in a multicapillary device for sample preparation according to the present invention.
- FIG. 7A is a chromatogram illustrating the performance of a multicapillary sample preparation device in sample enrichment as compared to a standard SPE cartridge, FIG. 7B .
- FIGS. 8A and 8B are mass spectra demonstrating the performance of a multicapillary sample preparation device in desalting of complex peptide mixtures.
- FIGS. 9A and 9B are mass spectra demonstrating the performance of a multicapillary sample preparation device in fractionating of complex peptide mixtures.
- FIG. 10 shows gels demonstrating sample capacity and recovery performance ( 10 A), reproducibility ( 10 B), and time performance ( 10 C) of a conventional device versus a multicapillary sample preparation device according to the present invention. Comparative data is shown in Table 2.
- FIG. 11A is a perspective view of a conventional spin column used for DNA purification.
- FIGS. 11B and 11C are SEM images of the spin column.
- FIGS. 12A and 12B respectively, show pulsed field and agarose gel electrophoresis analyses performed to determine DNA quality and size of a conventional spin column versus a multicapillary sample preparation device according to the present invention.
- FIGS. 13A and 13B respectively, show sample purification results of conventional spin columns versus a multicapillary sample preparation device of the present invention in terms of DNA yield and time required for sample preparation
- a parallel capillary array or multicapillary sample preparation device 12 is provided for use with commercially available pipettes to permit the isolation, purification, concentration and/or fractionation of biological samples in the micro- and nanoliter range, as well as larger mass loads and volumes.
- the invention includes both detachable and integrally embedded multicapillary devices 12 adapted for use with manual and automatic pipettes, micropipettes 20 , syringes 22 and other sample handling or analytical instruments.
- the multicapillary device 12 does not require use of a silica type porous substrate.
- a multicapillary device for sample preparation 12 comprising a monolithic element (rod, tube, etc.) 14 that has an upper end and a lower end, and defines a chamber.
- Capillary tubes 16 of uniform internal diameter and length are arranged within the chamber.
- Each capillary tube 16 includes a non-porous or imperforate wall having an inner and an outer surface, which defines an inner bore.
- Each tube 16 also includes a first and a second opening at opposing ends, so that resistance and backpressure are low.
- an insoluble stationary phase 18 on imperforate inner walls of the capillary tubes 16 .
- the insoluble stationary phase 18 comprise a polar material.
- the thickness of the stationary phase 18 is correlated with the radius of individual capillary tubes 16 to optimize efficiency of the multicapillary device 12 . As a result, during application of the stationary phase 18 , a greater amount settles on the inner surface of wider capillaries; while a smaller amount settles on the inner surface of narrower capillaries.
- the stationary phase film thickness d f is proportional to capillary radius r in power n, where n>1; c f is a constant.
- the thickness of the stationary phase coating 18 is proportional to the radius of the capillary tubes 16 in power n, where n is greater than 1.
- the stationary phase thickness d f is proportional to capillary radius r in power 3 .
- Stationary phase media 18 is retained on the interior surfaces of the imperforate, hollow capillary tubes 16 via stable chemical bonding or cross-linking. There is, therefore, no discharge of stationary phase media 18 into the mobile phase during separation, reducing sample contamination.
- supporting intermediary constituents and adsorptive and membranous plugs e.g., porous adsorbent silica particles or fibers
- the lumen or inner cavity of each capillary tube 16 remains unobstructed and impediment free throughout the protein, peptide, nucleic acid or biological sample separation process.
- sample molecules are incapable of diffusing between and through the imperforate walls of the capillary tubes 16 or from one capillary to another. Individual capillary tubes 16 remain physically and functionally independent of one another.
- the multicapillary device for sample preparation 12 may be detachably mounted (mechanically) or fixedly inserted (e.g., by melting or adhesion) about the end portion of a pipette tip, needle, tubing or other housing of suitable shape and dimension that is attachable to a pipette 20 .
- the multicapillary device 12 receives a sample in a mobile (liquid) phase at its first end, and a concentrated and purified sample, devoid of contaminants such as salts and buffers, is discharged at a second end of the device 12 .
- the structure of the multicapillary device 12 is distinctive and dissimilar to conventional spin columns and silica-based adsorptive and membranous “plugs” (see FIGS. 3 and 11 ), which feature irregular voids and vastly different sample pathways that entrap biological samples, such that more than half of the sample is usually unrecoverable.
- the multicapillary device 12 comprises a plurality of uniform capillary tubes 16 having an insoluble stationary phase media 18 on internal surfaces thereof, thereby permitting a sample inserted into the flow passage of the multicapillary device 12 to advance through open and virtually identical pathways.
- the inner cavity or flow passage of each capillary tube 16 thus remains unobstructed and impediment free throughout the sample separation process.
- purified (DNA) sample fragments extracted from the open and unobstructed capillary channels of the multicapillary device 12 comprise considerably larger fragments, representing a significant decrease in fragment breakage or “shearing.” These larger fragments generally reflect a better quality of purified sample as compared to conventional porous silica plugs used for sample processing.
- sample In the conventional adsorptive and membranous plugs, sample must travel through tortuous and irregular voids in the porous material, whereby portions of the sample lodge in small voids and are unrecoverable. Fragment shearing is thus unavoidable.
- the multicapillary device 12 of the present invention achieves substantial uniformity and consistency as compared to the sponge-like and expansive porous silica materials currently used for sample preparation.
- the multicapillary device 12 Due to the significant reduction in sample loss enabled by the open and unobstructed channel structure of the multicapillary device 12 , it is unnecessary for sample to be passed through the separation materials multiple times, as required in existing porous silica plugs, particles (for proteins and peptides), and fibers (for DNA and RNA). As a result, the multicapillary device 12 is generally reusable and fits conveniently with automatic instrumentation because there is no contamination due to sample carry-over. In short, the present multicapillary device 12 demonstrates superior characteristics over conventional adsorptive and membranous plugs with respect to binding capacity, recovery, increased throughput, uniformity and reproducibility.
- the imperforate inner walls of the capillary tubes 16 include particles of inert material or a nodular or uneven surface for increasing the surface area of the multicapillary device 12 .
- the inner wall may be altered using an etching process in combination with a solvent such as, for example, a mineral acid or base, or an organic acid or base.
- the present invention encompasses the use of any stationary phase 18 and surface chemistry adapted for liquid chromatography and sample preparation applications.
- the stationary phase media 18 deposited on inner surfaces of the capillary wall comprises a monolayer of organic molecules, biopolymers or larger particles.
- molecules and particles include, but are not limited to, hydrocarbons and their C-, N-, S- , and P-derivatives; proteins, nucleic acids, and polysaccharides; linear and cross-linked polysiloxanes and other polymers; and viruses and cells.
- a stationary phase coating 18 is formed by treating inner surfaces of the capillaries 16 with organosilicone compounds and further modifying these groups with appropriate reagents and particles.
- An alternative technique for the deposition of a stationary phase 18 involves polymerization of unsaturated compounds, such as butadiene, styrene, divinylbenzene, and others, on inner walls of the capillary tubes 16 .
- a stationary phase material 18 render the stationary phase material insoluble in organic and water-organic solvents commonly used in sample preparation and liquid chromatography, such as acetonitrile, methanol, isopropanol, acetone, dimethylsulfoxide, dimethylformamide and urea; acetic, iodoacetic, trifluoroacetic and formic acids; and phosphate, acetic and carbonate buffers, etc.
- the multicapillary sample preparation device 12 is advantageously suited for use with a wide range of sample preparation and analytical instruments. As shown in FIGS. 1, 4 , and 5 , these include, but are not limited to, manual and automatic pipettes and micropipettes 20 , syringes 22 , disposable devices, and automatic sample handling instruments. In some embodiments, the multicapillary device 12 is inserted about the terminal portion of a pipette tip 20 or other appropriate housing by, for example, sliding or press fitting, and is detachably retained in place by mechanical means such as elastic sealing rings and/or walls of the housing.
- the multicapillary device 12 is integrally and permanently embedded (e.g., cast-in-place) about the terminal region of a pipette tip 20 or other housing by melting, heat shrinking or adhesion in order to fuse the monolithic element 14 to the surface of a pipette tip 20 or other housing commonly made from polypropylene or other thermoplastic material.
- plasma and/or chemical means may be used to accomplish adhesion of the monolithic element 14 to the surface of the pipette tip 20 or other housing.
- the multicapillary device 12 is adapted to be detachably or fixedly engaged or aligned with the hollow flow passage(s) of a substantially cylindrical, conical or other housing configuration.
- the multicapillary device 12 is suitably sized and shaped to be integrated in housings of varying sizes and configurations.
- the housing it is preferable that the housing have a volume in the range of about 0.1 ⁇ L to about 100 mL, more preferably in the range of about 1 to about 1000 ⁇ L, and most preferably in the range of about 2 to about 200 ⁇ L.
- any technique used to install the multicapillary device 12 into a pipette tip or other housing for operation with a pipette 20 should accurately direct sample in a liquid phase through the capillary tubes 16 of the monolithic element 14 without bypassing the element 14 .
- the multicapillary device 12 receives the sample at its first end, and a concentrated and/or purified sample, devoid of contaminants such as salts and buffers, is discharged at a second end.
- the multicapillary device 12 of the present invention is freely permeable not only to proteins, peptides, polynucleotides, and other molecules and biopolymers, but also to viruses, spores, cells (e.g., cancer and stem), and microorganisms. It will be understood, however, that sample molecules are prevented from diffusing from one capillary tube 16 to another
- Preferred materials for fabricating the monolithic element 14 , capillary tubes 16 , tips, pipettes 20 , syringes 22 and other housings of the present invention include, but are not limited to, glass, fused silica, ceramic, metal (e.g., stainless steel), and plastic (e.g., polypropylene, polyethylene, polyolefin, or polyetheretherketone).
- metal e.g., stainless steel
- plastic e.g., polypropylene, polyethylene, polyolefin, or polyetheretherketone
- the number of capillary tubes 16 provided in a multicapillary device 12 may range from about 100 to about 1,000,000.
- the inner diameter of each capillary tube 16 may range from about 0.1 ⁇ m to about 200 ⁇ m.
- the outer diameter of the monolithic element 14 may range from about 0.1 mm to about 1 m, and the length may range from about 0.1 mm to about 2 m.
- the number of capillary tubes 16 ranges from about 1000 to about 10,000, the inner diameter of each capillary ranges from about 5 ⁇ m to about 100 ⁇ m, the outer diameter of the monolithic element 14 ranges from about 1 mm to about 20 mm, and the length ranges from about 1 mm to about 250 mm.
- a 5% solution of trimethylchlorosilane in toluene is pumped at 10 ⁇ L/min for six hours through a 1 mm outer diameter ⁇ 25 mm long multicapillary glass rod pierced with approximately 4400 capillaries of 10 ⁇ m diameter at 105° C.
- the multicapillary rod is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
- a 10% solution of butyldimethylchlorosilane in toluene is pumped at 40 ⁇ L/min for six hours through a 2 mm outer diameter ⁇ 300 mm long multicapillary glass rod pierced with approximately 4600 capillaries of 25 ⁇ m diameter at 105° C.
- the multicapillary rod is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
- a 10% solution of octyltrichlorosilane in toluene is pumped at 50 ⁇ L/min for six hours through a 2.3 mm outer diameter ⁇ 25 mm long multicapillary glass rod pierced with approximately 1400 capillaries of 40 ⁇ m diameter at 105° C.
- the multicapillary rod is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
- a 5% solution of dodecyltrichlorosilane in toluene is pumped at 75 ⁇ L/min for six hours through a 6 mm outer diameter ⁇ 300 mm long multicapillary glass rod pierced with approximately 3300 capillaries of 65 ⁇ m diameter at 105° C.
- the multicapillary rod is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
- a 10% solution of octadecyltriethoxysilane in toluene is pumped at 10 ⁇ L/min for six hours through a clean and dry 2.3 mm outer diameter ⁇ 300 mm multicapillary glass rod pierced with approximately 4,000 capillaries of 20 ⁇ m diameter at 105° C. While pumping the solution, an opposite end of the multicapillary device is moved at a linear speed of 0.5 mm/min inside an oven heated to 150° C. The device is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
- the stationary phases with C-16, C-30, phenyl, naphthyl and cyano groups are prepared, correspondingly, from hexadecyltrichlorosilane, triacontyltrichlorosilane, phenethyltrichlorosilane, (1-naphthylmethyl)trichlorosilane and 3-cyanopropyltrichlorosilane.
- the flask is equipped with a calcium chloride tube, and the mixture is slowly agitated at 0-5° C. for 48 hours.
- the liquid phase is separated and the multicapillary rods are repeatedly washed with methanol, water, 0.01 M HCl, water and tetrahydrofuran, and dried at room temperature.
- a 5% solution of (R)-N-1-phenylethyl-N-triethoxysilylpropylurea in toluene is pumped at 10 ⁇ L/min for six hours through a 1 mm outer diameter ⁇ 300 mm long multicapillary glass rod pierced with approximately 4000 capillaries of 10 ⁇ m diameter at 105° C.
- the multicapillary rod is rinsed with toluene, tetrahydrofuran and methanol, and dried with a nitrogen stream.
- the 10% solution of vinyltrichlorosilane in isooctane is pumped at 20 ⁇ L/min for six hours through a 1 mm outer diameter ⁇ 25 mm long multicapillary glass rod pierced with approximately 4,400 capillaries of 10 ⁇ m diameter at 90° C.
- the multicapillary rod is rinsed with isooctane, tetrahydrofuran, methanol, toluene and isooctane.
- a solution of 100 mg polybutadiene (MW 3,400) and 0.5 mg dicumyl peroxide in 100 mL of isooctane is pumped at 10 ⁇ L/min for six hours through the multicapillary rod at 90° C.
- the multicapillary rod is rinsed with toluene, tetrahydrofuran and methanol, and dried with a nitrogen stream.
- the mixture is slowly agitated at room temperature for 15 hours, and the liquid phase is separated.
- the multicapillary rods are repeatedly washed with 0.2 M phosphate buffer, pH 7.0, water, 0.2 M Tris buffer, pH 7.5, for two hours, and then washed with water and stored at 4° C.
- avidin, lectin and protein A stationary phases are prepared using avidin (from egg white), lectin (from Agaricus bisporus ), and protein A (from Staphylococcus aureus ), correspondingly.
- the liquid phase is separated and the multicapillary rods are repeatedly washed with methylene chloride, methanol, 90% methanol and water.
- the liquid phase is separated, and 5 mL of the 5 ⁇ g/mL solution of ricin antibody in 0.1 M phosphate buffered saline, pH 7.2, is added.
- the mixture is slowly agitated for two hours at room temperature.
- the liquid phase is separated.
- the multicapillary rods are repeatedly washed with phosphate buffered saline, pH 7.2, then washed with water and stored at 4° C.
- a 1 mm to 5 mm outer diameter multicapillary element 10 prepared as described in Example 6, is tightly pushed to the lower end of a polypropylene 10 ⁇ L to 5,000 ⁇ L volume micropipette tip.
- the lower portion of the pipette tip is placed for ten minutes in an oven thermostated at a temperature at which polypropylene begins to soften.
- Polypropylene pipette tip format multicapillary devices for sample preparation 12 , 20 are shown in FIGS. 4A and 4B .
- a 1 mm to 5 mm outer diameter multicapillary element 10 prepared as described in Example 6, is tightly placed in the lower end of a disposable polyethylene transfer pipette. The lower portion of the pipette is placed for ten minutes in an oven thermostated at a temperature at which polyethylene begins to soften.
- a polyethylene pipette format multicapillary device for sample preparation 12 , 20 is shown in FIG. 4C .
- a 2 mm outer diameter multicapillary element 10 prepared as described in Example 5, is attached to a heat shrinkable tubing.
- a removable syringe needle is attached to the second end of the heat shrinkable tubing.
- the heat shrinkable tubing zone is heated at a temperature recommended for the shrinkable tubing for ten minutes
- a representative syringe format multicapillary device for sample preparation 12 , 22 is shown in FIG. 5A .
- a 2.3 mm outer diameter multicapillary element 10 prepared as described in Example 5, is tightly placed in a removable thermoplastic syringe hub.
- the hub is heated for ten minutes in an oven thermostated at a temperature at which thermoplastic begins to soften.
- Syringe format multicapillary devices for sample preparation 12 , 22 are shown in FIGS. 5B and 5C .
- a three component mixture (uracil, fluorene, and phenanthrene) is separated on the multicapillary device for sample preparation prepared as described in Example 5 and installed on a model LC-600 Shimadzu liquid chromatographic instrument using standard HPLC fittings.
- the chromatographic conditions and chromatogram are reproduced in FIG. 6 .
- the chromatogram shows a uracil peak at about 1.8 minutes, a fluorene peak at about 2.1 minutes, and a phenanthrene peak at about 2.4 minutes.
- the example illustrates a liquid chromatographic application using the multicapillary device for sample preparation of the present invention, which enables a typical organic mixture to be analyzed in less than three minutes.
- a 2.3 mm outer diameter ⁇ 100 mm length multicapillary C-18 device for sample preparation containing approximately 1,400 capillaries of 40 ⁇ m diameter prepared as described in Example 5 is used for sample enrichment prior to HPLC analysis.
- SPE solid phase extraction
- multicapillary devices for sample preparation 12 are much faster, simpler and reusable.
- Performance of the present multicapillary device for sample preparation 12 ( FIG. 7A ) as compared to a standard SPE cartridge ( FIG. 7B ) is shown in Table 1. TABLE 1 Multicapillary Device vs. Conventional SPE Cartridge.
- the bovine serum albumin digest prepared as described in Example 34, is dried with a nitrogen stream and dissolved in 10 ⁇ L of 0.1% trifluoroacetic acid (TFA) in water. 1 ⁇ L of this sample is aspirated and dispensed from the multicapillary sample preparation device, as described in Examples 5 and 27. Three 10 ⁇ L portions of 0.1% trifluoroacetic acid (TFA) in 5% acetonitrile/water are pumped in and out of the multicapillary sample preparation device. The sample is eluted from the multicapillary sample preparation device with a 5 ⁇ L portion of 0.1% TFA in 70% acetonitrile/water and analyzed by MALDI-MS. The MALDI-MS spectra of the sample before and after desalting are shown in FIGS. 8A and 8B .
- the sample is eluted at 100 ⁇ L/min with 100 ⁇ L of 0.1% TFA in water followed by 30 ⁇ L of 0.1% TFA in 40% acetonitrile/water.
- Ten 3 ⁇ L 40% acetonitrile/water fractions are collected and analyzed by MALDI-MS.
- the mass-spectra of fractions 3 and 6 are shown in FIGS. 9A and 9B .
- This example illustrates the fractionating ability of the multicapillary sample preparation device of the present invention, prior to MALDI-MS analysis of a complex peptide mixture.
- FIGS. 10A and 10B depict gels produced to evaluate the sample capacity, recovery, and reproducibility of a multicapillary device for sample preparation according to the present invention, as compared to commercially available porous silica-based devices.
- Lanes 1 and 10 are protein standards inserted for purposes of comparison.
- Lanes 2 to 5 represent the conventional devices, while Lanes 3 to 10 denote the multicapillary sample preparation device of the instant invention.
- the test sample used for electrophoresis is a mixture of the following four representative proteins: Phosphorylase B (MW 97,400), Bovine Serum Albumin (MW 66,200), Carbonic Anhydrase (MW 31,000), and Lysozyme (MW 14,400). These proteins were selected due to their varying size and generally known properties. Moreover, these proteins are commonly used as standards. All results were reproduced and retested several times to ensure accuracy. Testing was conducted at ChromBA, Inc. (State College, Pa.), The Materials Research Institute (University Park, Pa.), The Milton Hershey Medical Center (Hershey, Pa.), Huck Institute (University Park, Pa.), APD LifeSciences Inc. (State College, Pa.), and MassTech Inc. (Columbia, Md.). In total, over 40 gels were used, including both C 18 and C 4 , the two most popular phases on the market. In addition, more than 500 sample preparation devices were tested.
- FIG. 10A Lanes 2-5; FIG. 10 B: Lanes 1-2
- the bands of the present device are clearly more identical from lane to lane demonstrating superior reproducibility.
- Table 2 further quantification reveals that the sample preparation device of the present invention, on average, binds and releases nearly twice the protein bound and released by conventional devices, and demonstrates half the margin of error (i.e., variance in amount of sample bound).
- FIG. 10C shows a gel produced to evaluate the speed of use (time performance) of a multicapillary device for sample preparation according to the present invention relative to commercially available silica-based devices.
- a sample must be passed through the tip of the silica-based devices approximately ten times to achieve suitable results. This is largely due to the fact that most of the sample travels through large voids in the filtration material and is subsequently not adsorbed and cleaned. Specifically, as illustrated by Lanes 1-4 of FIG. 10C , the conventional devices show faint bands even after ten passes through the tip.
- Lanes 5-10 show nearly identical spots for samples passed through the multicapillary device of the present invention only once. Notably, the bands are much darker and broader than those of the silica-based devices, denoting the presence of vastly greater amounts of protein.
- FIGS. 10A-10C the darkness and size of the bands on the gels developed by electrophoresis indicate the amount of protein bound by and recovered from the sample preparation devices; namely, pipette tips with integral silica-based plugs versus multicapillary elements.
- the superior performance of the multicapillary device 12 of the present invention is due, in part, to the uniform, consistent and virtually identical pathways for sample passage through the device, along with excellent tip-to-tip duplication, as shown in FIG. 2 .
- FIG. 3 and FIG. 11 depict cross-sections of commercially available (market leader) porous silica and silica fiber based sample preparation devices.
- the silica based devices reveal irregular particle sizes and fiber diameter, large voids (dark areas), and vastly different sample pathways.
- the conventional devices demonstrate poor tip-to-tip duplication (i.e., tremendous variance).
- a multicapillary device for sample preparation 12 (1 to 2.5 mm outer diameter, 0.25 to 3 cm long, approximately 4000 capillaries of 10 to 40 ⁇ m diameter, inner volume 2 to 90 ⁇ L) is loaded twice with 10 to 1,000 ⁇ L lysed biological sample. After discarding the loading solution, the multicapillary device 12 is rinsed with a washing buffer to dispose of proteins and other non-DNA type materials. Adsorbed DNA is then eluted with 10 to 300 ⁇ L elution buffer.
- the eluted DNA is analyzed using a variety of methods including Yo-Pro fluorescence on a Packard FluoroCount instrument at 530 nm (for yield determination), Agarose gel electrophoresis (for quality determination), and pulsed field gel electrophoresis (for DNA size and quality determination).
- FIGS. 13A and 13B are bar graphs comparing 16 rat liver samples' purification results in terms of DNA yield and time required for sample preparation using 25 ⁇ m ⁇ 1 cm ⁇ 200 ⁇ L pipette tip format multicapillary devices 12 , 20 according to the present invention and 16 commercially available (market leader) spin columns.
- the data for DNA yield was obtained using Yo-Pro fluorescence, and time was recorded with a stopwatch for each sample.
- the experiments demonstrate that the multicapillary devices 12 of the present invention are comparable to conventional spin columns in terms of DNA yield, but require significantly less time for processing. Notably, use of the present multicapillary devices results in a seven-fold decrease in “hands-on” labor time for DNA isolation sample preparation.
- FIG. 12B shows a 0.8% agarose gel run to analyze DNA extracted from whole bovine blood using the pipette tip format multicapillary devices (Lanes 1-7) and commercially available spin columns (Lanes 8-9), demonstrating comparable DNA yields and quality.
- pulsed field gel electrophoresis was used to size DNA strands of purified samples using the multicapillary device 12 of the present invention and commercially available spin columns.
- samples extracted using the present multicapillary device 12 demonstrate considerably larger DNA fragments, which suggests a significant decrease in DNA breakage or “shearing” during sample processing. Larger fragments of DNA reflect a better quality of the purified sample, which is highly desirable for many downstream applications such as PCR and sequencing.
- DNA shearing is unavoidable in specimens processed using the commercially available spin columns, which are operated by means of a centrifuge.
- DNA shearing is largely avoided through the use of an insoluble, surface-mediated mechanism of separation, which ensures that capillary channels (lumens) remain open and unobstructed throughout sample processing.
- Use of a gentle pipetting procedure for sample processing, in lieu of the commonly employed centrifuge, further contributes to the quality and size of DNA processed by means of the multicapillary devices 12 disclosed herein.
- Table 3 shows the adsorbance reading of five multicapillary devices 12 prepared according to the method described above.
- the average DNA recovery yield is 50-60%, which demonstrates that the multicapillary device for sample preparation 12 is efficacious for sample handling, purification and isolation of nucleic acids.
- a syringe format multicapillary device for sample preparation 12 , 22 (2.3 mm outer diameter, 150 mm long, approximately 1400 capillaries of 40 ⁇ m diameter, inner volume 262 ⁇ L) is attached to a syringe and rinsed with 1 mL of balanced salt solution creating an environment conductive to cell viability.
- a 1.5-3.0 mL volume of cell suspension is passed through the multicapillary device at a flow rate of 1 mL/min, followed by a 0.5 mL volume of balanced salt solution.
- the eluted cell suspension is concentrated by centrifugation and cells are counted using a hemacytometer.
- the change in cell viability after passage through the multicapillary device is presented in Table 4. TABLE 4 Cell Viability Upon Passage Through Multicapillary Device.
- the multicapillary device 12 of the present invention enables a user to achieve superior sample preparation results in significantly less time. Indeed, the device's 12 ability to return quality results quickly and reproducibly permits a user to increase the throughput of available sample preparation stations at least several times, depending upon the sample and system employed.
- the multicapillary sample preparation device 12 of the present invention advantageously increases sample throughput and decreases variance in a highly reproducible fashion.
- the multicapillary device 12 may be used in an array of applications without departing from the scope of the invention. These include, but are not limited to, sample handling of small molecules, polymers, viruses and cells; the isolation, purification, concentration, desalting and fractionation of biological samples and nucleic acids, including DNA and RNA; solid phase extraction; head space analysis; gas chromatography; liquid chromatography (e.g., HPLC); supercritical chromatography; electrochromatography; and capillary electrophoresis.
- Representative examples of the above-mentioned applications include: sample preparation of biological samples such as proteins, peptides, and polynucleotides, fractionation of peptide mixtures prior to mass-spectrometric analysis, desalting of samples prior to instrumental analysis, desalting of peptide solutions, desalting of protein solutions, sample concentration prior to instrumental analysis, and peptide concentration prior to mass-spectrometric analysis.
Abstract
Description
- This application claims benefit of U.S. patent application No. 10/955,377 filed Sep. 30, 2004, and U.S. Provisional Patent Application No. 60/507,474 filed Sep. 30, 2003.
- 1. Field of the Invention
- The present invention relates to a multicapillary sample preparation device especially useful for handling biological samples. In particular, the multicapillary device is suitable for use with a pipette, micropipette, syringe, or other similar analytical instrument.
- 2. Background Art
- Many biological samples are commonly separated by gel electrophoresis and analyzed by matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS). One disadvantage of these techniques, however, is that analysis is strongly affected by the presence of salts, buffers and low molecular weight organic compounds commonly used in the preparation of biological samples. In order to improve the sensitivity and selectivity of analyses, adsorptive and membranous devices are frequently used to purify and concentrate the sample prior to analysis. Such devices feature a bed of porous adsorbent or a semipermeable membrane fixed in a housing of a suitable dimension and shape that traps desired constituents, while allowing contaminants to pass.
- To handle samples in the 0.01 to 100 microgram (μg) range, pipettes, micropipettes, syringes or similar analytical instruments (collectively referred to hereinafter as “pipettes”) are commonly employed. The tip of these pipettes is fitted with one or more adsorptive or membranous plugs capable of purifying, concentrating, or fractionating peptides and other biomolecules.
- A principal shortcoming of adsorptive and membranous plugs, however, is that porous materials are generally not effective at separating smaller biomolecules such as proteins and polynucleotides. Porous plugs are also deficient with respect to isolating and purifying larger biological materials and nucleic acids such as DNA, RNA and cells. This shortcoming derives from the fact that during sample processing, molecules must wend through a labyrinth of sponge-like, expansive and porous adsorbent silica.
- There is little uniformity, consistency, and reproducibility of porous materials used for sample preparation. Sample loss in existing pipette tips is typically about 40-60%. Poor sample recovery is largely due to the fact that a sample must travel through irregular voids in the porous material, whereby a portion of the sample lodges in small voids and is unrecoverable. Moreover, in order to achieve adequate results, samples must be passed through porous materials multiple times (e.g., ten). The sample preparation devices are usually not reusable and fit poorly with automatic instrumentation because poor sample recovery may give rise to contamination due to sample carry-over.
- Spin columns and other apparatus operated by a centrifuge rotor are commonly used for the isolation and purification of biological and nucleic acid samples. However, it is desirable in certain applications to avoid the use of a centrifuge for rotating a specimen to be isolated and purified. This is due, in part, to the fact that horizontal separation may result in centrifugal forces of up to, for example, 4,000 RPM, being exerted on or transmitted along the vertical axis of the spin column and sample in order to achieve satisfactory separation. Air resistance negatively affects the spin column by generating drag and friction, which heat the spin column and its contents. Considerable breakage of sample fragments is unavoidable due to the heat transfer, acute centrifugal force and accompanying air resistance. The impaired quality of biological and nucleic acid samples extracted during spin column and centrifugal processing is highly undesirable to the user.
- It can be seen, therefore, that the purification and concentration of biological and nucleic acid samples using porous materials prior to instrumental analysis is time consuming, is poorly reproducible, has low throughput, and requires repeated passing of a sample through the porous plug.
- Accordingly, it is an object of the present invention to provide an efficient sample preparation device for use in isolating (immunoassay), purifying and concentrating samples of proteins, peptides, nucleic acids (e.g., DNA and RNA), and other biological materials (e.g., cells) prior to analysis.
- It is also an object of the invention to provide a sample preparation device with high sample capacity that increases throughput and reduces sample loss.
- It is a further object of the invention to provide a highly reproducible sample preparation device that achieves uniformity, consistency, and nearly identical pathways for sample passage.
- It is a still further object of the invention to provide a sample preparation device that is simple, cost-effective, and does not require the use of a silica type porous substrate or special equipment such as a centrifuge.
- The invention is a high surface area multicapillary sample preparation device especially useful for handling biological samples. The multicapillary device does not require use of a silica type porous substrate. Rather, the device incorporates a plurality of parallel capillary tubes, wherein the cavity of each tube remains open and unobstructed throughout sample processing. The capillary tubes of the device function independently of one another so that sample molecules are incapable of being physically exchanged or diffusing from one capillary to another. The multicapillary device is preferably disposed in a housing that is suitable for attachment to a “pipette” or other sample preparation or analytical instrument, enabling the isolation, purification, concentration and/or fractionation of nucleic acids or biological samples in the micro- and nanoliter range, as well as larger mass loads and volumes. In an embodiment of the invention, the multicapillary device features a monolithic element pierced with multiple uniform capillaries. The monolithic element is typically mounted in the lower end of a pipette tip, syringe needle or tubing, and is operated using a pipette.
- For protein separation and purification applications, an insoluble stationary phase material is deposited onto the interior surfaces (walls) of each capillary tube, without employing a supporting or intermediary constituent.
- The invention also includes a method of preparing a multicapillary device for protein sample preparation. In such method, inner walls of the capillary tubes are first coated with a stationary phase material, and then the monolithic element is mounted in an appropriate housing. Alternatively, the monolithic element can first be fixed in a housing, after which the capillary walls can be coated with the stationary phase. For operation, the multicapillary sample preparation device is attached to a pipette, micropipette, tube, syringe or similar analytical instrument.
-
FIG. 1 is a perspective view of a multicapillary device for sample preparation in accordance with an embodiment of the present invention. Individual capillaries of the device are shown in the enlarged, cross-sectional views ofFIGS. 2A, 2C and 2D (SEM).FIG. 2B is an exploded, perspective view of an individual capillary tube. -
FIG. 3 depicts SEM images showing cross-sectional views of a conventional sample preparation device. -
FIGS. 4A-4D are perspective views of pipette tips and a pipette format multicapillary device, respectively, in accordance with the present invention. -
FIGS. 5A-5C show perspective views of a syringe format multicapillary device for sample preparation according to the present invention. -
FIG. 6 is a chromatogram showing the separation of a three component mixture in a multicapillary device for sample preparation according to the present invention. -
FIG. 7A is a chromatogram illustrating the performance of a multicapillary sample preparation device in sample enrichment as compared to a standard SPE cartridge,FIG. 7B . -
FIGS. 8A and 8B are mass spectra demonstrating the performance of a multicapillary sample preparation device in desalting of complex peptide mixtures. -
FIGS. 9A and 9B are mass spectra demonstrating the performance of a multicapillary sample preparation device in fractionating of complex peptide mixtures. -
FIG. 10 shows gels demonstrating sample capacity and recovery performance (10A), reproducibility (10B), and time performance (10C) of a conventional device versus a multicapillary sample preparation device according to the present invention. Comparative data is shown in Table 2. -
FIG. 11A is a perspective view of a conventional spin column used for DNA purification.FIGS. 11B and 11C are SEM images of the spin column. -
FIGS. 12A and 12B , respectively, show pulsed field and agarose gel electrophoresis analyses performed to determine DNA quality and size of a conventional spin column versus a multicapillary sample preparation device according to the present invention. -
FIGS. 13A and 13B , respectively, show sample purification results of conventional spin columns versus a multicapillary sample preparation device of the present invention in terms of DNA yield and time required for sample preparation - In accordance with the present invention, a parallel capillary array or multicapillary
sample preparation device 12 is provided for use with commercially available pipettes to permit the isolation, purification, concentration and/or fractionation of biological samples in the micro- and nanoliter range, as well as larger mass loads and volumes. The invention includes both detachable and integrally embeddedmulticapillary devices 12 adapted for use with manual and automatic pipettes,micropipettes 20,syringes 22 and other sample handling or analytical instruments. Notably, themulticapillary device 12 does not require use of a silica type porous substrate. - Referring now to
FIGS. 1 and 2 , there is shown a multicapillary device forsample preparation 12 comprising a monolithic element (rod, tube, etc.) 14 that has an upper end and a lower end, and defines a chamber.Capillary tubes 16 of uniform internal diameter and length are arranged within the chamber. Eachcapillary tube 16 includes a non-porous or imperforate wall having an inner and an outer surface, which defines an inner bore. Eachtube 16 also includes a first and a second opening at opposing ends, so that resistance and backpressure are low. - For protein or peptide separation and purification applications, it is preferable to deposit an insoluble
stationary phase 18 on imperforate inner walls of thecapillary tubes 16. For the separation and purification of polar compounds such as nucleic acids (e.g., DNA and RNA), it is preferable that the insolublestationary phase 18 comprise a polar material. In a preferred embodiment of the invention, the thickness of thestationary phase 18 is correlated with the radius of individualcapillary tubes 16 to optimize efficiency of themulticapillary device 12. As a result, during application of thestationary phase 18, a greater amount settles on the inner surface of wider capillaries; while a smaller amount settles on the inner surface of narrower capillaries. Through this process, thecapillaries 16 achieve quasi-uniformity, which substantially increases the efficiency of themulticapillary device 12. The following relationship for high peak efficiency has been derived by the inventors:
d f(r)=c r ·r n (Equation 1) - The stationary phase film thickness df is proportional to capillary radius r in power n, where n>1; cf is a constant.
- In a more preferred embodiment, the thickness of the
stationary phase coating 18 is proportional to the radius of thecapillary tubes 16 in power n, where n is greater than 1. - To achieve the highest peak efficiency, the stationary phase thickness df is proportional to capillary radius r in
power 3. -
Stationary phase media 18 is retained on the interior surfaces of the imperforate,hollow capillary tubes 16 via stable chemical bonding or cross-linking. There is, therefore, no discharge ofstationary phase media 18 into the mobile phase during separation, reducing sample contamination. In the open tubular system of themulticapillary device 12, supporting intermediary constituents and adsorptive and membranous plugs (e.g., porous adsorbent silica particles or fibers) are unnecessary. The lumen or inner cavity of eachcapillary tube 16 remains unobstructed and impediment free throughout the protein, peptide, nucleic acid or biological sample separation process. In this stable, surface-mediated mechanism of separation, sample molecules are incapable of diffusing between and through the imperforate walls of thecapillary tubes 16 or from one capillary to another.Individual capillary tubes 16 remain physically and functionally independent of one another. - The multicapillary device for
sample preparation 12 may be detachably mounted (mechanically) or fixedly inserted (e.g., by melting or adhesion) about the end portion of a pipette tip, needle, tubing or other housing of suitable shape and dimension that is attachable to apipette 20. Themulticapillary device 12 receives a sample in a mobile (liquid) phase at its first end, and a concentrated and purified sample, devoid of contaminants such as salts and buffers, is discharged at a second end of thedevice 12. - As shown in
FIGS. 2A, 2B and 2C (Scanning Electron Microscope image), the structure of themulticapillary device 12 is distinctive and dissimilar to conventional spin columns and silica-based adsorptive and membranous “plugs” (seeFIGS. 3 and 11 ), which feature irregular voids and vastly different sample pathways that entrap biological samples, such that more than half of the sample is usually unrecoverable. Themulticapillary device 12 comprises a plurality of uniformcapillary tubes 16 having an insolublestationary phase media 18 on internal surfaces thereof, thereby permitting a sample inserted into the flow passage of themulticapillary device 12 to advance through open and virtually identical pathways. The inner cavity or flow passage of eachcapillary tube 16 thus remains unobstructed and impediment free throughout the sample separation process. - As shown in
FIGS. 12 and 13 , purified (DNA) sample fragments extracted from the open and unobstructed capillary channels of themulticapillary device 12 comprise considerably larger fragments, representing a significant decrease in fragment breakage or “shearing.” These larger fragments generally reflect a better quality of purified sample as compared to conventional porous silica plugs used for sample processing. In the conventional adsorptive and membranous plugs, sample must travel through tortuous and irregular voids in the porous material, whereby portions of the sample lodge in small voids and are unrecoverable. Fragment shearing is thus unavoidable. With its open and unobstructed channel structure, themulticapillary device 12 of the present invention achieves substantial uniformity and consistency as compared to the sponge-like and expansive porous silica materials currently used for sample preparation. - Due to the significant reduction in sample loss enabled by the open and unobstructed channel structure of the
multicapillary device 12, it is unnecessary for sample to be passed through the separation materials multiple times, as required in existing porous silica plugs, particles (for proteins and peptides), and fibers (for DNA and RNA). As a result, themulticapillary device 12 is generally reusable and fits conveniently with automatic instrumentation because there is no contamination due to sample carry-over. In short, thepresent multicapillary device 12 demonstrates superior characteristics over conventional adsorptive and membranous plugs with respect to binding capacity, recovery, increased throughput, uniformity and reproducibility. - In one embodiment of the invention, the imperforate inner walls of the
capillary tubes 16 include particles of inert material or a nodular or uneven surface for increasing the surface area of themulticapillary device 12. In such case, the inner wall may be altered using an etching process in combination with a solvent such as, for example, a mineral acid or base, or an organic acid or base. - The present invention encompasses the use of any
stationary phase 18 and surface chemistry adapted for liquid chromatography and sample preparation applications. In some embodiments, thestationary phase media 18 deposited on inner surfaces of the capillary wall comprises a monolayer of organic molecules, biopolymers or larger particles. Such molecules and particles include, but are not limited to, hydrocarbons and their C-, N-, S- , and P-derivatives; proteins, nucleic acids, and polysaccharides; linear and cross-linked polysiloxanes and other polymers; and viruses and cells. In other embodiments, astationary phase coating 18 is formed by treating inner surfaces of thecapillaries 16 with organosilicone compounds and further modifying these groups with appropriate reagents and particles. - An alternative technique for the deposition of a
stationary phase 18 involves polymerization of unsaturated compounds, such as butadiene, styrene, divinylbenzene, and others, on inner walls of thecapillary tubes 16. - The techniques used for deposition of a
stationary phase material 18, described in the following Examples, render the stationary phase material insoluble in organic and water-organic solvents commonly used in sample preparation and liquid chromatography, such as acetonitrile, methanol, isopropanol, acetone, dimethylsulfoxide, dimethylformamide and urea; acetic, iodoacetic, trifluoroacetic and formic acids; and phosphate, acetic and carbonate buffers, etc. - The multicapillary
sample preparation device 12 is advantageously suited for use with a wide range of sample preparation and analytical instruments. As shown inFIGS. 1, 4 , and 5, these include, but are not limited to, manual and automatic pipettes andmicropipettes 20,syringes 22, disposable devices, and automatic sample handling instruments. In some embodiments, themulticapillary device 12 is inserted about the terminal portion of apipette tip 20 or other appropriate housing by, for example, sliding or press fitting, and is detachably retained in place by mechanical means such as elastic sealing rings and/or walls of the housing. - In other embodiments, the
multicapillary device 12 is integrally and permanently embedded (e.g., cast-in-place) about the terminal region of apipette tip 20 or other housing by melting, heat shrinking or adhesion in order to fuse themonolithic element 14 to the surface of apipette tip 20 or other housing commonly made from polypropylene or other thermoplastic material. As an alternative, plasma and/or chemical means may be used to accomplish adhesion of themonolithic element 14 to the surface of thepipette tip 20 or other housing. - In yet another embodiment, the
multicapillary device 12 is adapted to be detachably or fixedly engaged or aligned with the hollow flow passage(s) of a substantially cylindrical, conical or other housing configuration. Themulticapillary device 12 is suitably sized and shaped to be integrated in housings of varying sizes and configurations. However, it is preferable that the housing have a volume in the range of about 0.1 μL to about 100 mL, more preferably in the range of about 1 to about 1000 μL, and most preferably in the range of about 2 to about 200 μL. - It will be understood that any technique used to install the
multicapillary device 12 into a pipette tip or other housing for operation with apipette 20 should accurately direct sample in a liquid phase through thecapillary tubes 16 of themonolithic element 14 without bypassing theelement 14. In such adaptation, themulticapillary device 12 receives the sample at its first end, and a concentrated and/or purified sample, devoid of contaminants such as salts and buffers, is discharged at a second end. Themulticapillary device 12 of the present invention is freely permeable not only to proteins, peptides, polynucleotides, and other molecules and biopolymers, but also to viruses, spores, cells (e.g., cancer and stem), and microorganisms. It will be understood, however, that sample molecules are prevented from diffusing from onecapillary tube 16 to another - Preferred materials for fabricating the
monolithic element 14,capillary tubes 16, tips, pipettes 20,syringes 22 and other housings of the present invention include, but are not limited to, glass, fused silica, ceramic, metal (e.g., stainless steel), and plastic (e.g., polypropylene, polyethylene, polyolefin, or polyetheretherketone). In sample preparation and chromatographic applications, it is desirable to employ a large number (e.g. hundreds or thousands) of capillary tubes to provide an abundant surface area for higher sample loading capacity. It will be understood, however, that the number and dimensions of themulticapillary device 12,stationary phase media 18, solvent, tips and other housings employed in the invention will vary according to application. - As an example, the number of
capillary tubes 16 provided in amulticapillary device 12 may range from about 100 to about 1,000,000. The inner diameter of eachcapillary tube 16 may range from about 0.1 μm to about 200 μm. The outer diameter of themonolithic element 14 may range from about 0.1 mm to about 1 m, and the length may range from about 0.1 mm to about 2 m. In a preferred embodiment, the number ofcapillary tubes 16 ranges from about 1000 to about 10,000, the inner diameter of each capillary ranges from about 5 μm to about 100 μm, the outer diameter of themonolithic element 14 ranges from about 1 mm to about 20 mm, and the length ranges from about 1 mm to about 250 mm. - C-1 Stationary Phase
- A 5% solution of trimethylchlorosilane in toluene is pumped at 10 μL/min for six hours through a 1 mm outer diameter×25 mm long multicapillary glass rod pierced with approximately 4400 capillaries of 10 μm diameter at 105° C. The multicapillary rod is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
- C-4 Stationary Phase
- A 10% solution of butyldimethylchlorosilane in toluene is pumped at 40 μL/min for six hours through a 2 mm outer diameter×300 mm long multicapillary glass rod pierced with approximately 4600 capillaries of 25 μm diameter at 105° C. The multicapillary rod is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
- C-8 Stationary Phase
- A 10% solution of octyltrichlorosilane in toluene is pumped at 50 μL/min for six hours through a 2.3 mm outer diameter×25 mm long multicapillary glass rod pierced with approximately 1400 capillaries of 40 μm diameter at 105° C. The multicapillary rod is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
- C-12 Stationary Phase
- A 5% solution of dodecyltrichlorosilane in toluene is pumped at 75 μL/min for six hours through a 6 mm outer diameter×300 mm long multicapillary glass rod pierced with approximately 3300 capillaries of 65 μm diameter at 105° C. The multicapillary rod is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
- C-18
Stationary Phase 1 - A 10% solution of octadecyltriethoxysilane in toluene is pumped at 10 μL/min for six hours through a clean and dry 2.3 mm outer diameter×300 mm multicapillary glass rod pierced with approximately 4,000 capillaries of 20 μm diameter at 105° C. While pumping the solution, an opposite end of the multicapillary device is moved at a linear speed of 0.5 mm/min inside an oven heated to 150° C. The device is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
- C-18
Stationary Phase 2 - Twenty 1 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 4400 capillaries of 10 μm diameter are placed in a flask containing 50 mL of a 5% solution of octadecyldimethylchlorosilane in toluene and equipped with a reflux condenser and a calcium chloride tube. The mixture is slowly refluxed for six hours. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran and methanol, and dried at room temperature.
- C-16, C-30, Phenyl, Naphthyl, and Cyano Stationary Phases
- In accordance with the conditions described in Example 6, the stationary phases with C-16, C-30, phenyl, naphthyl and cyano groups are prepared, correspondingly, from hexadecyltrichlorosilane, triacontyltrichlorosilane, phenethyltrichlorosilane, (1-naphthylmethyl)trichlorosilane and 3-cyanopropyltrichlorosilane.
- Epoxide Stationary Phase
- Twenty 2.3 mm outer diameter×5 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% solution of (3-glycidoxypropyl)trimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. to remove the methanol formed from the reaction. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran and methanol, and dried at room temperature.
- Diol
Stationary Phase 1 - Twenty 2.3 mm outer diameter×3 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% solution of (3-glycidoxypropyl)trimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for three hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran, methanol and water. 50 mL of water is added and the pH is adjusted to 2.0 with nitric acid. The mixture is slowly agitated for two hours at room temperature. The liquid phase is separated and the multicapillary rods are washed with water until the wash is neutral, then washed three times with methanol, and dried at room temperature.
- Diol
Stationary Phase 2 - 2.5 g of (3-glycidoxypropyl)trimethoxysilane is dropped into a flask containing 50 mL of water, while maintaining the pH between 5 and 6 with 0.01 M potassium hydroxide. Twenty 2.3 mm outer diameter×5 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask. The mixture is slowly refluxed for three hours with a reflux condenser. The liquid phase is separated and the multicapillary rods are repeatedly washed with water, methanol and tetrahydrofuran. 50 mL of water is added and the pH is adjusted to 2.0 with nitric acid. The mixture is slowly agitated for two hours at room temperature. The liquid phase is separated and the multicapillary rods are washed with water until the wash is neutral, then washed three times with methanol, and dried at room temperature.
- Amino Stationary Phase
- Twenty-five 1 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 4400 capillaries of 10 μm diameter are placed in a flask containing 50 mL of a 5% solution of 3-aminopropyltrimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran and methanol, and dried at room temperature.
- Trimethylammonium Stationary Phase
- Thirty 2.3 mm outer diameter×5 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% solution of 3-aminopropyltrimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for six hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran and methanol. 30 mL of a 5% solution of trimethylamine in methanol is added to the flask. The flask is equipped with a calcium chloride tube, and the mixture is slowly agitated at 0-5° C. for 48 hours. The liquid phase is separated and the multicapillary rods are repeatedly washed with methanol, water, 0.01 M HCl, water and tetrahydrofuran, and dried at room temperature.
- Carboxylic Acid Stationary Phase
- Twenty 2.3 mm outer diameter×5 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% water solution of carboxyethylsilane triol (sodium salt). The pH is adjusted to 2.0 by adding hydrochloric acid. The mixture is slowly refluxed for three hours with a reflux condenser. The liquid phase is separated and the multicapillary rods are washed with water until the wash is neutral, then washed three times with methanol, and dried at room temperature.
- Sulfonic Stationary Phase
- Twenty-five 2.3 mm outer diameter×3 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% water solution of 3-(trihydroxysilyl)-1-propanesulfonic acid. The mixture is slowly refluxed for three hours with a reflux condenser. The liquid phase is separated and the multicapillary rods are washed with water until the wash is neutral, then washed three times with methanol, and dried at room temperature.
- Phosphonic Stationary Phase
- Thirty 2.3 mm outer diameter×3 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% water solution of (3-trihydroxysilylpropyl)methylphosphonate sodium salt. The mixture is acidified to pH 2.0 with HCL and slowly refluxed for three hours with a reflux condenser. The liquid phase is separated and the multicapillary rods are washed with water until the wash is neutral, then washed three times with methanol, and dried at room temperature.
- Iminodiacetic Acid Stationary Phase
- Twenty 1 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 4400 capillaries of 10 μm diameter are placed in a flask containing 50 mL of a 5% solution of (3-glycidoxypropyl)trimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran, methanol and water. 20 mL of a 2 M iminodiacetic acid solution in 0.1 M sodium borate buffer, pH 8.5, is added and the mixture is slowly agitated for 24 hours at room temperature. The liquid phase is separated and the multicapillary rods are washed with water until the wash is neutral, then washed three times with methanol, and dried at room temperature.
- Cystein Stationary Phase
- Twenty-five 1 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 4400 capillaries of 10 μm diameter are placed in a flask containing 50 mL of a 5% solution of 3-bromopropyltrimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran and methanol. 50 mL of a 1% solution of cystein in methanol and 1 mL of triethylamine are added, and the mixture is slowly refluxed with a reflux condenser for five hours. The liquid phase is separated and the multicapillary rods are repeatedly washed with methanol, water, methanol and methylene chloride, and dried at room temperature.
- Glutathione Stationary Phase
- Twenty 1 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 4400 capillaries of 10 μm diameter are placed in a flask containing 50 mL of a 5% solution of 11-bromoundecyltrimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran and methanol. 50 mL of a 0.5% solution of glutathione in methanol and 1 mL of triethylamine are added, and the mixture is slowly refluxed with a reflux condenser for five hours. The liquid phase is separated and the multicapillary rods are repeatedly washed with methanol, water, methanol and methylene chloride, and dried at room temperature.
- Chiral Stationary Phase
- A 5% solution of (R)-N-1-phenylethyl-N-triethoxysilylpropylurea in toluene is pumped at 10 μL/min for six hours through a 1 mm outer diameter×300 mm long multicapillary glass rod pierced with approximately 4000 capillaries of 10 μm diameter at 105° C. The multicapillary rod is rinsed with toluene, tetrahydrofuran and methanol, and dried with a nitrogen stream.
- Polybutadiene Stationary Phase
- The 10% solution of vinyltrichlorosilane in isooctane is pumped at 20 μL/min for six hours through a 1 mm outer diameter×25 mm long multicapillary glass rod pierced with approximately 4,400 capillaries of 10 μm diameter at 90° C. The multicapillary rod is rinsed with isooctane, tetrahydrofuran, methanol, toluene and isooctane. A solution of 100 mg polybutadiene (MW 3,400) and 0.5 mg dicumyl peroxide in 100 mL of isooctane is pumped at 10 μL/min for six hours through the multicapillary rod at 90° C. The multicapillary rod is rinsed with toluene, tetrahydrofuran and methanol, and dried with a nitrogen stream.
- Biotin Stationary Phase
- Twenty five 1 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 4400 capillaries of 10 μm diameter are placed in a flask containing 50 mL of a 5% solution of 3-aminopropyltrimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, methanol and dimethylformamide. 15 mL of a saturated dimethylformamide solution of biotin, a solution of 0.3 g of 1-hydroxybenzotriazole hydrate in 10 mL of dimethylformamide, and a solution of 0.25 g of N, N-dicyclohehylcarbodiimide in 10 mL of dimethylformamide are added, and the mixture is slowly agitated for five hours at room temperature. The liquid phase is separated and the multicapillary rods are repeatedly washed with dimethylformamide, methanol, water, methanol and methylene chloride, and dried at room temperature.
- Heparin Stationary Phase
- Twenty 2.3 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% solution of 3-aminopropyltrimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, methanol, water and 0.05 M 2-morpholinoethane sulfonic acid buffer, pH 5.6. The 10 mL solution of 0.2 g heparin (from bovine kidney), 1 g N-(3-dimethylaminopropyl)-N-ethylcarbodiimide, and 0.5 g N-hydroxysuccinimide in 0.05 M 2-morpholinoethane sulfonic acid buffer, pH 5.6, is added. The mixture is slowly agitated for three hours at room temperature. The liquid phase is separated, and the multicapillary rods are repeatedly washed with water, phosphate buffer,
pH - Glycoprotein Stationary Phase
- Twenty 2.3 mm outer diameter×3 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 20 mL of a 5% solution of (3-glycidoxypropyl)trimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, methanol and water. The 4 mL solution of 100 mg alpha1 acid (from bovine plasma) in a 1:1 mixture of 0.4 M sodium chloride and 0.2 M borate buffer, pH 8.5, is added. The mixture is slowly agitated at room temperature for 48 hours. The liquid phase is separated. The multicapillary rods are repeatedly washed with a 1:1 mixture of 0.4 M sodium chloride and 0.2 M borate buffer, pH 8.5, then washed with water and stored at 4° C.
- Trypsin Stationary Phase
- Twenty 2 mm outer diameter×5 mm long multicapillary glass rods pierced with approximately 4600 capillaries of 25 μm diameter are placed in a flask containing 20 mL of a 5% solution of (3-glycidoxypropyl)trimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, methanol and water. A 7 mL solution of 100 mg trypsin (from bovine pancreas) in 0.2 M phosphate buffer, pH 7.0, is added to the flask. The mixture is slowly agitated at room temperature for 15 hours, and the liquid phase is separated. The multicapillary rods are repeatedly washed with 0.2 M phosphate buffer, pH 7.0, water, 0.2 M Tris buffer, pH 7.5, for two hours, and then washed with water and stored at 4° C.
- Avidin, Lectin, and Protein A Stationary Phases
- In accordance with the conditions described in Example 24, avidin, lectin and protein A stationary phases are prepared using avidin (from egg white), lectin (from Agaricus bisporus), and protein A (from Staphylococcus aureus), correspondingly.
- Antibody Stationary Phase
- Twenty 2.3 mm outer diameter×3 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% solution of 10-(carbomethoxy)decyldimethylmethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for three hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated, and the multicapillary rods are repeatedly washed with toluene, methanol and methylene chloride. A 35 mL solution of 1 mL trimethyliodosilane in methylene chloride is added. The mixture is slowly agitated for 72 hours at room temperature.
- The liquid phase is separated and the multicapillary rods are repeatedly washed with methylene chloride, methanol, 90% methanol and water. 20 mL of 0.02 M ethyl(dimethylaminopropyl)-carbodiimide in 0.1 M 2-morpholinoethanesulfonic acid buffer, pH 4.5, is added, and the mixture is slowly agitated for one hour at room temperature. The liquid phase is separated, and 5 mL of the 5 μg/mL solution of ricin antibody in 0.1 M phosphate buffered saline, pH 7.2, is added. The mixture is slowly agitated for two hours at room temperature. The liquid phase is separated. The multicapillary rods are repeatedly washed with phosphate buffered saline, pH 7.2, then washed with water and stored at 4° C.
- Polypropylene Pipette Tip Format Multicapillary Sample Preparation Device
- A 1 mm to 5 mm outer
diameter multicapillary element 10, prepared as described in Example 6, is tightly pushed to the lower end of apolypropylene 10 μL to 5,000 μL volume micropipette tip. The lower portion of the pipette tip is placed for ten minutes in an oven thermostated at a temperature at which polypropylene begins to soften. Polypropylene pipette tip format multicapillary devices forsample preparation FIGS. 4A and 4B . - Polyethylene Pipette Format Multicapillary Sample Preparation Device
- A 1 mm to 5 mm outer
diameter multicapillary element 10, prepared as described in Example 6, is tightly placed in the lower end of a disposable polyethylene transfer pipette. The lower portion of the pipette is placed for ten minutes in an oven thermostated at a temperature at which polyethylene begins to soften. A polyethylene pipette format multicapillary device forsample preparation FIG. 4C . - Syringe Format Multicapillary Sample
Preparation Device # 1 - A 2 mm outer
diameter multicapillary element 10, prepared as described in Example 5, is attached to a heat shrinkable tubing. A removable syringe needle is attached to the second end of the heat shrinkable tubing. The heat shrinkable tubing zone is heated at a temperature recommended for the shrinkable tubing for ten minutes A representative syringe format multicapillary device forsample preparation FIG. 5A . - Syringe Format Multicapillary Sample
Preparation Devices # 2 and #3 - A 2.3 mm outer
diameter multicapillary element 10, prepared as described in Example 5, is tightly placed in a removable thermoplastic syringe hub. The hub is heated for ten minutes in an oven thermostated at a temperature at which thermoplastic begins to soften. Syringe format multicapillary devices forsample preparation FIGS. 5B and 5C . - Separation of Three Component Mixture
- A three component mixture (uracil, fluorene, and phenanthrene) is separated on the multicapillary device for sample preparation prepared as described in Example 5 and installed on a model LC-600 Shimadzu liquid chromatographic instrument using standard HPLC fittings. The chromatographic conditions and chromatogram are reproduced in
FIG. 6 . The chromatogram shows a uracil peak at about 1.8 minutes, a fluorene peak at about 2.1 minutes, and a phenanthrene peak at about 2.4 minutes. The example illustrates a liquid chromatographic application using the multicapillary device for sample preparation of the present invention, which enables a typical organic mixture to be analyzed in less than three minutes. - Sample Enrichment for HPLC Analysis
- Referring to
FIG. 7A , a 2.3 mm outer diameter×100 mm length multicapillary C-18 device for sample preparation containing approximately 1,400 capillaries of 40 μm diameter prepared as described in Example 5 is used for sample enrichment prior to HPLC analysis. At present, short HPLC columns known as solid phase extraction (“SPE”) cartridges are commonly used for sample preparation. Compared to SPE cartridges, multicapillary devices forsample preparation 12 are much faster, simpler and reusable. Performance of the present multicapillary device for sample preparation 12 (FIG. 7A ) as compared to a standard SPE cartridge (FIG. 7B ) is shown in Table 1.TABLE 1 Multicapillary Device vs. Conventional SPE Cartridge. Characteristics SPE Cartridge Multicapillary Device 1 Collection time 20-40 minutes 1-5 minutes 2 Amount 1-5 ml samples 100-200 μl samples 3 Processing the Extract volume No concentration extract 5-20 ml or evaporation of Requires the extract required evaporation for analysis 4 Reconditioning Cannot be Reconditioned by reconditioned washing with methanol and water for 2 min. 5 Reusability Cannot be Can be reused at reused least 50-100 times depending on the sample to be extracted 6 Silica particles Fine silica No silica or other in the sample particles in the particles in the samples samples 7 Auto samplers Cannot be Easily adaptable adaptability used in auto to auto samplers samplers 8 Field use Difficult Requires only syringes to transport Costly equipment/ accessories - Hydrolysis of Bovine Serum Albumin
- A 10 μL volume of 0.25 mg/mL bovine serum albumin solution in a 40:60 mixture of acetonitrile and 0.2 mM ammonium bicarbonate, pH 7.5, is aspirated in the multicapillary sample preparation device, prepared as described in Example 24, and thermostated at 37° C. After five minutes, the digested sample is dispensed in a vial and stored at 4° C.
- Desalting of Peptide Samples
- The bovine serum albumin digest, prepared as described in Example 34, is dried with a nitrogen stream and dissolved in 10 μL of 0.1% trifluoroacetic acid (TFA) in water. 1 μL of this sample is aspirated and dispensed from the multicapillary sample preparation device, as described in Examples 5 and 27. Three 10 μL portions of 0.1% trifluoroacetic acid (TFA) in 5% acetonitrile/water are pumped in and out of the multicapillary sample preparation device. The sample is eluted from the multicapillary sample preparation device with a 5 μL portion of 0.1% TFA in 70% acetonitrile/water and analyzed by MALDI-MS. The MALDI-MS spectra of the sample before and after desalting are shown in
FIGS. 8A and 8B . - Fractionating of Peptides
- A 3 μL volume of the 100 pmole/μL peptide mixture obtained by the enzymatic hydrolysis of bovine serum albumin, as described in Example 34, is introduced into a 10 cm long C-18 multicapillary sample preparation device. The sample is eluted at 100 μL/min with 100 μL of 0.1% TFA in water followed by 30 μL of 0.1% TFA in 40% acetonitrile/water. Ten 3 μL 40% acetonitrile/water fractions are collected and analyzed by MALDI-MS. The mass-spectra of
fractions FIGS. 9A and 9B . This example illustrates the fractionating ability of the multicapillary sample preparation device of the present invention, prior to MALDI-MS analysis of a complex peptide mixture. - Gel Electrophoresis of Proteins
-
FIGS. 10A and 10B depict gels produced to evaluate the sample capacity, recovery, and reproducibility of a multicapillary device for sample preparation according to the present invention, as compared to commercially available porous silica-based devices.Lanes Lanes 2 to 5 represent the conventional devices, whileLanes 3 to 10 denote the multicapillary sample preparation device of the instant invention. - The test sample used for electrophoresis is a mixture of the following four representative proteins: Phosphorylase B (MW 97,400), Bovine Serum Albumin (MW 66,200), Carbonic Anhydrase (MW 31,000), and Lysozyme (MW 14,400). These proteins were selected due to their varying size and generally known properties. Moreover, these proteins are commonly used as standards. All results were reproduced and retested several times to ensure accuracy. Testing was conducted at ChromBA, Inc. (State College, Pa.), The Materials Research Institute (University Park, Pa.), The Milton Hershey Medical Center (Hershey, Pa.), Huck Institute (University Park, Pa.), APD LifeSciences Inc. (State College, Pa.), and MassTech Inc. (Columbia, Md.). In total, over 40 gels were used, including both C18 and C4, the two most popular phases on the market. In addition, more than 500 sample preparation devices were tested.
- In both figures, the conventional silica-based devices (
FIG. 10A : Lanes 2-5; FIG. 10B: Lanes 1-2) show faint and varying bands. In contrast, the device of the present invention (FIG. 10A : Lanes 6-9;FIG. 10B : Lanes 3-10) shows bold and dark bands, indicating vastly superior binding capacity, and recovery. Moreover, the bands of the present device are clearly more identical from lane to lane demonstrating superior reproducibility. As shown in Table 2, further quantification reveals that the sample preparation device of the present invention, on average, binds and releases nearly twice the protein bound and released by conventional devices, and demonstrates half the margin of error (i.e., variance in amount of sample bound).TABLE 2 Sample Capacity, Recovery Performance, and Reproducibility of Multicapillary Device vs. Conventional Devices. MEAN VALUE % OF AVERAGE OF BAND INCREASED MARGIN INTENSITY CAPACITY OF ERROR Convent. Multicap. Multicap. Convent. Multicap. PROTEIN Device Device Device Device Device FIG. Phosphorylase B 45.7 56.2 23% 5.8% 3.4% 10A Bovine Serum 85.2 162.1 91% Albumin Carbonic 86.8 131.4 51% Anhydrase Lysozyme 84.2 151.6 79% FIG. Phosphorylase B — — — — — 10B Bovine Serum 85.5 135.1 107% 6.3% 3.8% Albumin Carbonic 70.1 108.6 55% Anhydrase Lysozyme 77.0 157.6 104% -
FIG. 10C shows a gel produced to evaluate the speed of use (time performance) of a multicapillary device for sample preparation according to the present invention relative to commercially available silica-based devices. As recommended by the manufacturers, a sample must be passed through the tip of the silica-based devices approximately ten times to achieve suitable results. This is largely due to the fact that most of the sample travels through large voids in the filtration material and is subsequently not adsorbed and cleaned. Specifically, as illustrated by Lanes 1-4 ofFIG. 10C , the conventional devices show faint bands even after ten passes through the tip. - In contrast, Lanes 5-10 show nearly identical spots for samples passed through the multicapillary device of the present invention only once. Notably, the bands are much darker and broader than those of the silica-based devices, denoting the presence of vastly greater amounts of protein.
- In
FIGS. 10A-10C , the darkness and size of the bands on the gels developed by electrophoresis indicate the amount of protein bound by and recovered from the sample preparation devices; namely, pipette tips with integral silica-based plugs versus multicapillary elements. The superior performance of themulticapillary device 12 of the present invention is due, in part, to the uniform, consistent and virtually identical pathways for sample passage through the device, along with excellent tip-to-tip duplication, as shown inFIG. 2 .FIG. 3 andFIG. 11 , in contrast, depict cross-sections of commercially available (market leader) porous silica and silica fiber based sample preparation devices. The silica based devices reveal irregular particle sizes and fiber diameter, large voids (dark areas), and vastly different sample pathways. Moreover, the conventional devices demonstrate poor tip-to-tip duplication (i.e., tremendous variance). - Isolation of Nucleic Acids
- The following experiments, featuring both
syringe 22 andpipette tip 20format multicapillary devices 12, demonstrate the advantage of using a multicapillary device for sample handling and extraction of DNA from various biological samples, such as tissue, blood, bacterial cells, urine, etc. - A multicapillary device for sample preparation 12 (1 to 2.5 mm outer diameter, 0.25 to 3 cm long, approximately 4000 capillaries of 10 to 40 μm diameter,
inner volume 2 to 90 μL) is loaded twice with 10 to 1,000 μL lysed biological sample. After discarding the loading solution, themulticapillary device 12 is rinsed with a washing buffer to dispose of proteins and other non-DNA type materials. Adsorbed DNA is then eluted with 10 to 300 μL elution buffer. The eluted DNA is analyzed using a variety of methods including Yo-Pro fluorescence on a Packard FluoroCount instrument at 530 nm (for yield determination), Agarose gel electrophoresis (for quality determination), and pulsed field gel electrophoresis (for DNA size and quality determination). -
FIGS. 13A and 13B , respectively, are bar graphs comparing 16 rat liver samples' purification results in terms of DNA yield and time required for sample preparation using 25 μm×1 cm×200 μL pipette tipformat multicapillary devices multicapillary devices 12 of the present invention are comparable to conventional spin columns in terms of DNA yield, but require significantly less time for processing. Notably, use of the present multicapillary devices results in a seven-fold decrease in “hands-on” labor time for DNA isolation sample preparation. - Agarose gel electrophoresis and pulsed field gel electrophoresis analyses were performed to determine DNA quality and size.
FIG. 12B shows a 0.8% agarose gel run to analyze DNA extracted from whole bovine blood using the pipette tip format multicapillary devices (Lanes 1-7) and commercially available spin columns (Lanes 8-9), demonstrating comparable DNA yields and quality. Further, as shown inFIG. 12A , pulsed field gel electrophoresis was used to size DNA strands of purified samples using themulticapillary device 12 of the present invention and commercially available spin columns. As compared to the leading spin columns, samples extracted using thepresent multicapillary device 12 demonstrate considerably larger DNA fragments, which suggests a significant decrease in DNA breakage or “shearing” during sample processing. Larger fragments of DNA reflect a better quality of the purified sample, which is highly desirable for many downstream applications such as PCR and sequencing. - As demonstrated in
FIGS. 12 and 13 , significant DNA shearing is unavoidable in specimens processed using the commercially available spin columns, which are operated by means of a centrifuge. In themulticapillary device 12 of the present invention, however, DNA shearing is largely avoided through the use of an insoluble, surface-mediated mechanism of separation, which ensures that capillary channels (lumens) remain open and unobstructed throughout sample processing. Use of a gentle pipetting procedure for sample processing, in lieu of the commonly employed centrifuge, further contributes to the quality and size of DNA processed by means of themulticapillary devices 12 disclosed herein. - Table 3 shows the adsorbance reading of five
multicapillary devices 12 prepared according to the method described above. The average DNA recovery yield is 50-60%, which demonstrates that the multicapillary device forsample preparation 12 is efficacious for sample handling, purification and isolation of nucleic acids.TABLE 3 DNA Isolation on Multicapillary Device. Fluorescence Reading Sample (Units) Blank elution buffer 21 Elution buffer spiked with 16 μg/mL DNA 214 Eluted DNA from MC 211 Eluted DNA from MC 211 Eluted DNA from MC 217 Eluted DNA from MC 238 Eluted DNA from MC 213 - Sample Handling of Cells
- To demonstrate the use of a
multicapillary device 12 for sample handling of cells, the following cells are grown and evaluated: mouse myeloma Sp2/0-Ag14, approximately 25 μm size; mouse macrophage J774A1, approximately 15 μm size; and human prostrate tumor THP-1 approximately 20 μm size. A syringe format multicapillary device forsample preparation 12, 22 (2.3 mm outer diameter, 150 mm long, approximately 1400 capillaries of 40 μm diameter, inner volume 262 μL) is attached to a syringe and rinsed with 1 mL of balanced salt solution creating an environment conductive to cell viability. At room temperature, a 1.5-3.0 mL volume of cell suspension is passed through the multicapillary device at a flow rate of 1 mL/min, followed by a 0.5 mL volume of balanced salt solution. The eluted cell suspension is concentrated by centrifugation and cells are counted using a hemacytometer. The change in cell viability after passage through the multicapillary device is presented in Table 4.TABLE 4 Cell Viability Upon Passage Through Multicapillary Device. Viable % Viable Suspension Concentration Cells Viable Cells Cells Cell Volume of Cells Initial Recovered Recovered Sp2/0-Ag14 3.0 mL 1 × 106 cells/mL 2.73 × 106 2.09 × 106 76.5 J774A1 2.0 mL 3.5 × 106 cells/mL 6.30 × 106 3.57 × 106 56.6 THP-1 2.0 mL 3.5 × 106 cells/mL 6.65 × 106 5.06 × 106 76.1 - The data reveal that the vast majority of each cell type passed through the device emerges unharmed. Therefore, the multicapillary device for sample preparation is highly efficacious for sample handling of cells.
- Manufacturers of existing pipette tips state in their technical literature that 40-60% sample loss is average for a purified product. In comparison, the increased capacity and recovery afforded by the present invention substantially reduces and/or eliminates the critical problem of sample loss in the pipette tip. Moreover, equipment wear is reduced, since the present invention eschews repeat sample passage, as required by conventional silica-based devices.
- As demonstrated by the foregoing Examples 1-38, the
multicapillary device 12 of the present invention enables a user to achieve superior sample preparation results in significantly less time. Indeed, the device's 12 ability to return quality results quickly and reproducibly permits a user to increase the throughput of available sample preparation stations at least several times, depending upon the sample and system employed. - In short, the multicapillary
sample preparation device 12 of the present invention advantageously increases sample throughput and decreases variance in a highly reproducible fashion. Themulticapillary device 12 may be used in an array of applications without departing from the scope of the invention. These include, but are not limited to, sample handling of small molecules, polymers, viruses and cells; the isolation, purification, concentration, desalting and fractionation of biological samples and nucleic acids, including DNA and RNA; solid phase extraction; head space analysis; gas chromatography; liquid chromatography (e.g., HPLC); supercritical chromatography; electrochromatography; and capillary electrophoresis. - Representative examples of the above-mentioned applications include: sample preparation of biological samples such as proteins, peptides, and polynucleotides, fractionation of peptide mixtures prior to mass-spectrometric analysis, desalting of samples prior to instrumental analysis, desalting of peptide solutions, desalting of protein solutions, sample concentration prior to instrumental analysis, and peptide concentration prior to mass-spectrometric analysis.
- While the invention has been particularly shown and described with reference to the examples and preferred embodiments thereof, it will be understood by those skilled in the art that various alterations in form and detail may be made therein without departing from the spirit and scope of the invention.
Claims (25)
d f(r)=c f ·r n
d f(r)=c f ·r n
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/524,426 US20070017870A1 (en) | 2003-09-30 | 2006-09-20 | Multicapillary device for sample preparation |
US13/015,400 US8980093B2 (en) | 2003-09-30 | 2011-01-27 | Multicapillary device for sample preparation |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50747403P | 2003-09-30 | 2003-09-30 | |
US10/955,377 US7166212B2 (en) | 2003-09-30 | 2004-09-30 | Multicapillary column for chromatography and sample preparation |
US11/524,426 US20070017870A1 (en) | 2003-09-30 | 2006-09-20 | Multicapillary device for sample preparation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/955,377 Continuation-In-Part US7166212B2 (en) | 2003-09-30 | 2004-09-30 | Multicapillary column for chromatography and sample preparation |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/015,400 Continuation US8980093B2 (en) | 2003-09-30 | 2011-01-27 | Multicapillary device for sample preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070017870A1 true US20070017870A1 (en) | 2007-01-25 |
Family
ID=46123976
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/524,426 Abandoned US20070017870A1 (en) | 2003-09-30 | 2006-09-20 | Multicapillary device for sample preparation |
US13/015,400 Active 2025-04-16 US8980093B2 (en) | 2003-09-30 | 2011-01-27 | Multicapillary device for sample preparation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/015,400 Active 2025-04-16 US8980093B2 (en) | 2003-09-30 | 2011-01-27 | Multicapillary device for sample preparation |
Country Status (1)
Country | Link |
---|---|
US (2) | US20070017870A1 (en) |
Cited By (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050186685A1 (en) * | 2004-01-17 | 2005-08-25 | Gyros Ab | Protecting agent |
US20070075007A1 (en) * | 2003-09-30 | 2007-04-05 | Belov Yuri P | Multicapillary column for chromatography and sample preparation |
US20080233594A1 (en) * | 2005-01-17 | 2008-09-25 | Gyros Patent Ab | Method For Detecting An At Least Bivalent Analyte Using Two Affinity Reactants |
US20090200166A1 (en) * | 2008-02-08 | 2009-08-13 | Arkray, Inc. | Method of Analyzing Hemoglobin by Capillary Eletrophoresis |
US20090255949A1 (en) * | 2008-04-11 | 2009-10-15 | Pelican Group Holdings, Inc. | Pipette tip handling devices and methods |
US20100089938A1 (en) * | 2008-04-11 | 2010-04-15 | Arta Motadel | Pipette tip handling devices and methods |
US20100155242A1 (en) * | 2006-09-04 | 2010-06-24 | Arkray, Inc. | Method of Analyzing a Sample by Capillary Electrophoresis |
US20100175996A1 (en) * | 2006-09-04 | 2010-07-15 | Arkray, Inc. | Process for analyzing sample by capillary electrophoresis method |
US20100187110A1 (en) * | 2006-09-04 | 2010-07-29 | National Institute Of Advanced Industrial Science And Technology | Process for analyzing sample by capillary electrophoresis method |
US20100218622A1 (en) * | 2009-01-12 | 2010-09-02 | Biotix, Inc. | Flexible pipette tips |
US20100219093A1 (en) * | 2009-01-13 | 2010-09-02 | Biotix, Inc. | Manufacture processes for assessing pipette tip quality |
US20100221151A1 (en) * | 2009-01-23 | 2010-09-02 | Biotix, Inc. | Anti-static pipette tip trays |
US20100258578A1 (en) * | 2009-04-11 | 2010-10-14 | Biotix, Inc. | Automated pipette tip loading devices and methods |
US20110092686A1 (en) * | 2008-03-28 | 2011-04-21 | Pelican Group Holdings, Inc. | Multicapillary sample preparation devices and methods for processing analytes |
US20110165327A1 (en) * | 2010-01-01 | 2011-07-07 | Samsung Mobile Display Co., Ltd. | Thin film deposition apparatus |
US7985188B2 (en) | 2009-05-13 | 2011-07-26 | Cv Holdings Llc | Vessel, coating, inspection and processing apparatus |
US20110183433A1 (en) * | 2010-01-22 | 2011-07-28 | Biotix, Inc. | Pipette tips |
US8512796B2 (en) | 2009-05-13 | 2013-08-20 | Si02 Medical Products, Inc. | Vessel inspection apparatus and methods |
USD697227S1 (en) | 2009-04-11 | 2014-01-07 | Biotix, Inc. | Pipette tip handling device set |
US8795606B2 (en) | 2012-05-30 | 2014-08-05 | Biotix, Inc. | Integrated pipette tip devices |
US8980093B2 (en) | 2003-09-30 | 2015-03-17 | Yuri P. Belov | Multicapillary device for sample preparation |
RU2547597C1 (en) * | 2013-09-27 | 2015-04-10 | Юлия Сергеевна Скибина | Multi-channel nozzle for extraction of nucleic acids, proteins and peptides |
USD731075S1 (en) * | 2013-03-15 | 2015-06-02 | Nalge Nunc International Corporation | Pipette |
US20150279648A1 (en) * | 2014-03-26 | 2015-10-01 | Li-Cor, Inc. | Laser desorption ionization mass spectrometry using a particulate separation bed |
US9272095B2 (en) | 2011-04-01 | 2016-03-01 | Sio2 Medical Products, Inc. | Vessels, contact surfaces, and coating and inspection apparatus and methods |
FR3026312A1 (en) * | 2014-09-29 | 2016-04-01 | Francois Parmentier | PROCESS FOR CHROMATOGRAPHY ON A GEL OR ORGANIC LIQUID |
US9458536B2 (en) | 2009-07-02 | 2016-10-04 | Sio2 Medical Products, Inc. | PECVD coating methods for capped syringes, cartridges and other articles |
US9545360B2 (en) | 2009-05-13 | 2017-01-17 | Sio2 Medical Products, Inc. | Saccharide protective coating for pharmaceutical package |
US9554968B2 (en) | 2013-03-11 | 2017-01-31 | Sio2 Medical Products, Inc. | Trilayer coated pharmaceutical packaging |
US9664626B2 (en) | 2012-11-01 | 2017-05-30 | Sio2 Medical Products, Inc. | Coating inspection method |
US9662450B2 (en) | 2013-03-01 | 2017-05-30 | Sio2 Medical Products, Inc. | Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus |
US9764093B2 (en) | 2012-11-30 | 2017-09-19 | Sio2 Medical Products, Inc. | Controlling the uniformity of PECVD deposition |
US9863042B2 (en) | 2013-03-15 | 2018-01-09 | Sio2 Medical Products, Inc. | PECVD lubricity vessel coating, coating process and apparatus providing different power levels in two phases |
US9878101B2 (en) | 2010-11-12 | 2018-01-30 | Sio2 Medical Products, Inc. | Cyclic olefin polymer vessels and vessel coating methods |
US9903782B2 (en) | 2012-11-16 | 2018-02-27 | Sio2 Medical Products, Inc. | Method and apparatus for detecting rapid barrier coating integrity characteristics |
US9937099B2 (en) | 2013-03-11 | 2018-04-10 | Sio2 Medical Products, Inc. | Trilayer coated pharmaceutical packaging with low oxygen transmission rate |
USD815753S1 (en) | 2014-12-10 | 2018-04-17 | Biotix, Inc. | Pipette tip sheet |
US10137453B2 (en) | 2014-12-10 | 2018-11-27 | Biotix, Inc. | Static-defeating apparatus for pipette tips |
US10189603B2 (en) | 2011-11-11 | 2019-01-29 | Sio2 Medical Products, Inc. | Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus |
US10201660B2 (en) | 2012-11-30 | 2019-02-12 | Sio2 Medical Products, Inc. | Controlling the uniformity of PECVD deposition on medical syringes, cartridges, and the like |
USD849962S1 (en) | 2014-12-10 | 2019-05-28 | Biotix, Inc. | Pipette tip retention sheet |
US10343156B2 (en) | 2013-03-15 | 2019-07-09 | Nalge Nunc International Corporation | Tapered pipette |
USD865216S1 (en) | 2014-12-10 | 2019-10-29 | Biotix, Inc. | Pipette tip sheet |
WO2019217098A1 (en) | 2018-05-11 | 2019-11-14 | Biotix, Inc. | Pipette tip |
US10730053B2 (en) | 2014-12-10 | 2020-08-04 | Biotix, Inc. | Static-defeating apparatus for pipette tips |
USD905865S1 (en) | 2018-05-11 | 2020-12-22 | Biotix, Inc. | Pipette tip |
US10946374B2 (en) | 2017-05-17 | 2021-03-16 | Biotix, Inc. | Ergonomic pipette tips |
EP3831489A1 (en) | 2010-01-22 | 2021-06-09 | Biotix, Inc. | Pipette tips |
US11066745B2 (en) | 2014-03-28 | 2021-07-20 | Sio2 Medical Products, Inc. | Antistatic coatings for plastic vessels |
US11077233B2 (en) | 2015-08-18 | 2021-08-03 | Sio2 Medical Products, Inc. | Pharmaceutical and other packaging with low oxygen transmission rate |
US11116695B2 (en) | 2011-11-11 | 2021-09-14 | Sio2 Medical Products, Inc. | Blood sample collection tube |
US11624115B2 (en) | 2010-05-12 | 2023-04-11 | Sio2 Medical Products, Inc. | Syringe with PECVD lubrication |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10041747B2 (en) * | 2010-09-22 | 2018-08-07 | Raytheon Company | Heat exchanger with a glass body |
WO2014116813A1 (en) * | 2013-01-25 | 2014-07-31 | Douglas Scientific | Silica-based biological material isolation |
US20160318014A1 (en) * | 2015-05-01 | 2016-11-03 | Molecular Bioproducts, Inc. | Thin walled pipette tip |
Citations (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3570673A (en) * | 1968-09-07 | 1971-03-16 | Jenaer Glaswerk Schott & Gen | Separation column for liquid chromatography |
US4043905A (en) * | 1974-08-26 | 1977-08-23 | Indiana University Foundation | Chromatographic separation columns with selectively modified active surfaces and methods for their preparations |
US4045352A (en) * | 1973-05-23 | 1977-08-30 | California Institute Of Technology | Ion-exchange hollow fibers |
US4214020A (en) * | 1977-11-17 | 1980-07-22 | Monsanto Company | Processes for coating bundles of hollow fiber membranes |
US4293413A (en) * | 1979-12-28 | 1981-10-06 | Baxter Travenol Laboratories, Inc. | Dialyzer blood circuit and bubble traps |
US4293415A (en) * | 1979-04-27 | 1981-10-06 | Hewlett-Packard Company | Silica chromatographic column |
US4424127A (en) * | 1980-03-07 | 1984-01-03 | Johan Roeraade | Column for liquid and gas chromatography |
US4654265A (en) * | 1985-06-05 | 1987-03-31 | Ube Industries, Ltd. | Porous hollow fiber |
US4657742A (en) * | 1985-07-01 | 1987-04-14 | Ppg Industries, Inc. | Packed fiber glass reaction vessel |
US4689267A (en) * | 1984-07-26 | 1987-08-25 | Shin-Etsu Chemical Co., Ltd. | Composite hollow fiber |
US4818264A (en) * | 1987-04-30 | 1989-04-04 | The Dow Chemical Company | Multicapillary gas chromatography column |
US4957620A (en) * | 1988-11-15 | 1990-09-18 | Hoechst Celanese Corporation | Liquid chromatography using microporous hollow fibers |
US4999164A (en) * | 1986-10-20 | 1991-03-12 | Eppendorf-Netheler-Hinz Gmbh | Pipetting device comprising a retaining cone for holding a slip-on pipette tip and pipette tip for such pipetting device |
US5092219A (en) * | 1987-07-08 | 1992-03-03 | Thermedics Inc. | Selective decomposition of nitrite esters and nitramines |
US5154822A (en) * | 1986-07-28 | 1992-10-13 | 3I Research Exploitation Limited | Bonded chromatographic stationary phase |
US5194333A (en) * | 1989-12-18 | 1993-03-16 | Tosoh Corporation | Packing material for reversed phase chromatography and process for its preparation |
US5395521A (en) * | 1991-05-31 | 1995-03-07 | Board Of Regents, The University Of Texas System | Automated column equilibration, column loading, column washing and column elution |
US5429746A (en) * | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
US5438127A (en) * | 1993-09-27 | 1995-08-01 | Becton Dickinson And Company | DNA purification by solid phase extraction using a PCl3 modified glass fiber membrane |
US5460781A (en) * | 1989-10-27 | 1995-10-24 | Fujirebio Kabushiki Kaisha | Hemoglobin sampler |
US5552047A (en) * | 1994-05-24 | 1996-09-03 | Terumo Kabushiki Kaisha | Hollow filament blood processing apparatus |
US5774779A (en) * | 1996-11-06 | 1998-06-30 | Materials And Electrochemical Research (Mer) Corporation | Multi-channel structures and processes for making such structures |
US5876918A (en) * | 1993-03-08 | 1999-03-02 | Hydros, Inc. | Aligned fiber diagnostic chromatography with positive and negative controls |
US6045757A (en) * | 1997-06-30 | 2000-04-04 | Rainin Instrument Co., Inc. | Membrane filter pipette tip |
US6048457A (en) * | 1997-02-26 | 2000-04-11 | Millipore Corporation | Cast membrane structures for sample preparation |
US6117394A (en) * | 1996-04-10 | 2000-09-12 | Smith; James C. | Membrane filtered pipette tip |
US6123905A (en) * | 1997-01-17 | 2000-09-26 | Matrix Technologies Corporation | Pipettor including an indicator and method of use |
US6168948B1 (en) * | 1995-06-29 | 2001-01-02 | Affymetrix, Inc. | Miniaturized genetic analysis systems and methods |
US6174352B1 (en) * | 1998-11-24 | 2001-01-16 | Uop Llc | Round profile multi-capillary assembly and method of making |
US6174673B1 (en) * | 1997-06-16 | 2001-01-16 | Diversa Corporation | High throughput screening for novel enzymes |
US6207049B1 (en) * | 1999-07-30 | 2001-03-27 | Agilent Technologies, Inc. | Multichannel capillary column |
US6231739B1 (en) * | 1998-09-11 | 2001-05-15 | The Perkin-Elmer Corporation | Multi-channel capillary electrophoresis device including sheath-flow cuvette and replacable capillary array |
US6270674B1 (en) * | 1997-06-14 | 2001-08-07 | Akzo Nobel Nv | Membrane module with unilaterally embedded hollow fiber membranes |
US6306659B1 (en) * | 1996-06-28 | 2001-10-23 | Caliper Technologies Corp. | High throughput screening assay systems in microscale fluidic devices |
US6309828B1 (en) * | 1998-11-18 | 2001-10-30 | Agilent Technologies, Inc. | Method and apparatus for fabricating replicate arrays of nucleic acid molecules |
US6338802B1 (en) * | 1998-10-29 | 2002-01-15 | Pe Corporation (Ny) | Multi-well microfiltration apparatus |
US6357484B1 (en) * | 1998-08-31 | 2002-03-19 | Uop Llc | Microporous structure defined by a multiplicity of singular channels and method of making |
US6387331B1 (en) * | 1998-01-12 | 2002-05-14 | Massachusetts Institute Of Technology | Method and apparatus for performing microassays |
US6406921B1 (en) * | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
US6416716B1 (en) * | 2001-04-20 | 2002-07-09 | Ashok Kumar Shukla | Sample preparation device with embedded separation media |
US20020110495A1 (en) * | 2001-01-05 | 2002-08-15 | Denis Hunt | Devices and methods for purification |
US6451260B1 (en) * | 1997-08-26 | 2002-09-17 | Dyax Corp. | Method for producing microporous elements, the microporous elements thus produced and uses thereof |
US20030007897A1 (en) * | 2001-07-06 | 2003-01-09 | Andrew Creasey | Pipette tips |
US6537502B1 (en) * | 2000-07-25 | 2003-03-25 | Harvard Apparatus, Inc. | Surface coated housing for sample preparation |
US20030068317A1 (en) * | 2001-04-20 | 2003-04-10 | William Lee | High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon |
US6566145B2 (en) * | 2000-02-09 | 2003-05-20 | William E Brewer | Disposable pipette extraction |
US6576478B1 (en) * | 1998-07-14 | 2003-06-10 | Zyomyx, Inc. | Microdevices for high-throughput screening of biomolecules |
US6596237B1 (en) * | 1998-04-27 | 2003-07-22 | Nicholas F. Borrelli | Redrawn capillary imaging reservoir |
US20030173284A1 (en) * | 2000-05-13 | 2003-09-18 | Baker Matthew John | Separation device |
US6638482B1 (en) * | 1993-11-01 | 2003-10-28 | Nanogen, Inc. | Reconfigurable detection and analysis apparatus and method |
US20040038316A1 (en) * | 1999-05-10 | 2004-02-26 | Robert Kaiser | Cell separation device and methods for use |
US6759126B1 (en) * | 1998-09-21 | 2004-07-06 | University Of South Florida | Solid phase microextraction fiber structure and method of making |
US20040147042A1 (en) * | 1999-05-28 | 2004-07-29 | Miklos Gratzl | Device for precise chemical delivery and solution preparation |
US6780314B2 (en) * | 2000-11-01 | 2004-08-24 | Shinwa Chemical Industries, Ltd. | Separation column for chromatography, medium for solid phase extraction and sample injection system for chromatography |
US6780582B1 (en) * | 1998-07-14 | 2004-08-24 | Zyomyx, Inc. | Arrays of protein-capture agents and methods of use thereof |
US6794127B1 (en) * | 1997-06-16 | 2004-09-21 | Diversa Corporation | Capillary array-based sample screening |
US20040191537A1 (en) * | 2001-06-13 | 2004-09-30 | Dieter Lubda | Restricted access material for spme |
US20050003211A1 (en) * | 2000-09-05 | 2005-01-06 | Hitachi, Ltd. | Removal method for coating of polymer coated glass capillary tubing and polymer coated glass capillary tubing |
US6870165B2 (en) * | 2001-10-19 | 2005-03-22 | Biocal Technology, Inc. | Multi-color multiplexed analysis in a bio-separation system |
US6886824B2 (en) * | 1998-08-25 | 2005-05-03 | Minolta Co., Ltd. | Binding member removing apparatus, automatic document feeder, sheet processing apparatus, and image forming apparatus |
US20050139536A1 (en) * | 2003-09-30 | 2005-06-30 | Belov Yuri P. | Multicapillary column for chromatography and sample preparation |
US20050178709A1 (en) * | 2004-01-23 | 2005-08-18 | Ngk Insulators, Ltd. | Supports for solid phase extraction |
US6992181B2 (en) * | 1999-10-28 | 2006-01-31 | Gyros Ab | DNA isolation method |
US20060062701A1 (en) * | 2002-07-18 | 2006-03-23 | Hiroyuki Nakamura | Method of manufacturing microwave reaction device and microwave reaction device |
US20060093518A1 (en) * | 2004-10-29 | 2006-05-04 | Shukla Ashok K | Device containing non-covalently bound biomolecules on solid support |
US20060118491A1 (en) * | 2004-12-03 | 2006-06-08 | Gjerde Douglas T | Method and device for desalting an analyte |
US20060201881A1 (en) * | 2004-08-10 | 2006-09-14 | Clemson University | Capillary-channeled polymeric fiber as solid phase extraction media |
US20060216206A1 (en) * | 2003-05-29 | 2006-09-28 | Hudson William C | Solid phase extraction pipette |
US7118657B2 (en) * | 1999-06-22 | 2006-10-10 | President And Fellows Of Harvard College | Pulsed ion beam control of solid state features |
US7118671B2 (en) * | 2003-04-30 | 2006-10-10 | Institute For Roentgen Optics | Polycapillary chromatographic column and method of its manufacturing |
US7122640B2 (en) * | 2002-06-10 | 2006-10-17 | Phynexus, Inc. | Open channel solid phase extraction systems and methods |
US20070071649A1 (en) * | 2001-09-10 | 2007-03-29 | Marcus R Kenneth | Capillary-channeled polymer fibers as stationary phase media for spectroscopic analysis |
US7208072B2 (en) * | 2002-01-18 | 2007-04-24 | Biocal Technology, Inc. | Multi-segment cartridge for bio-separation with multiplexed fluorescence detection |
US20070111194A1 (en) * | 2003-12-15 | 2007-05-17 | Preentec Ag | Method for the concentration and purification of biological compounds |
US20070116607A1 (en) * | 2005-11-23 | 2007-05-24 | Pharmacom Microlelectronics, Inc. | Microsystems that integrate three-dimensional microarray and multi-layer microfluidics for combinatorial detection of bioagent at single molecule level |
US7247469B2 (en) * | 1998-07-14 | 2007-07-24 | Zyomyx, Inc. | Non-specific binding resistant protein arrays and methods for making the same |
US7271895B2 (en) * | 2004-04-09 | 2007-09-18 | Institute For Roentgen Optics | Fluorescent sensor on basis of multichannel structures |
US20070215543A1 (en) * | 2006-03-14 | 2007-09-20 | Mettler-Toledo Autochem, Inc. | Small volume liquid-liquid extraction device and method of use |
US7759112B2 (en) * | 2007-10-31 | 2010-07-20 | Akonni Biosystems, Inc. | Apparatus, system, and method for purifying nucleic acids |
US20110092686A1 (en) * | 2008-03-28 | 2011-04-21 | Pelican Group Holdings, Inc. | Multicapillary sample preparation devices and methods for processing analytes |
US20110107855A1 (en) * | 2008-03-28 | 2011-05-12 | Pelican Group Holdings, Inc. | Sample preparation devices and methods for processing analytes |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4283272A (en) | 1980-06-12 | 1981-08-11 | Mobil Oil Corporation | Manufacture of hydrocracked low pour lubricating oils |
CH654666A5 (en) | 1982-01-21 | 1986-02-28 | Eidgenoess Oberzolldirektion | Separation column for liquid chromatography |
JPS61265567A (en) | 1985-05-20 | 1986-11-25 | Fujikura Ltd | Multi-capillary column |
US5683916A (en) | 1988-10-31 | 1997-11-04 | Hemasure Inc. | Membrane affinity apparatus and purification methods related thereto |
US5160627A (en) * | 1990-10-17 | 1992-11-03 | Hoechst Celanese Corporation | Process for making microporous membranes having gel-filled pores, and separations methods using such membranes |
JPH0827621B2 (en) | 1991-07-12 | 1996-03-21 | ヤマハ株式会社 | Electronic musical instrument |
US5362859A (en) | 1992-07-27 | 1994-11-08 | Sepracor, Inc. | High-capacity affinity supports and methods for the preparation and use of same |
CA2105962A1 (en) | 1992-09-18 | 1994-03-19 | Margaret Patricia Raybuck | Device and method for affinity separation |
DE4234728A1 (en) | 1992-10-15 | 1994-04-21 | Peter Prof Dr Bartholmes | Process for the recovery and the buffering and / or concentration of dissolved macromolecules of a macromolecule mixture |
RU2060498C1 (en) | 1993-01-11 | 1996-05-20 | Институт катализа Сибирского отделения РАН | Chromatographic column |
DE4443754C2 (en) | 1994-12-08 | 1996-09-26 | Daimler Benz Ag | Gas chromatograph |
US5552042A (en) | 1995-02-24 | 1996-09-03 | Uop | Rigid silica capillary assembly |
US6972183B1 (en) | 1997-06-16 | 2005-12-06 | Diversa Corporation | Capillary array-based enzyme screening |
RU2114427C1 (en) | 1996-09-27 | 1998-06-27 | Конструкторско-технологический институт геофизического и экологического приборостроения СО РАН | Polycapillary chromatographic column |
US5851491A (en) | 1997-06-13 | 1998-12-22 | Labcon, North America | Pipette tip and filter for accurate sampling and prevention of contamination |
EP0926492A1 (en) | 1997-12-02 | 1999-06-30 | Uop Llc | Round profile multi-capillary assembly useful in chromatography |
US6007609A (en) | 1997-12-18 | 1999-12-28 | Uop Llc | Pressurized container with restrictor tube having multiple capillary passages |
JPH11295282A (en) | 1998-04-10 | 1999-10-29 | Rieko Naito | Tip for pipet |
JPH11349692A (en) | 1998-06-04 | 1999-12-21 | Key Tranding Co Ltd | Article having frosted glass tone and its preparation |
ES2214865T3 (en) | 1998-06-24 | 2004-09-16 | CHEN & CHEN, LLC | MULTICAPE ANALYTICAL COLUMN. |
US6333088B1 (en) | 1999-01-13 | 2001-12-25 | Uop Llc | Compound capillary assembly and use in separative transport |
US6143252A (en) | 1999-04-12 | 2000-11-07 | The Perkin-Elmer Corporation | Pipetting device with pipette tip for solid phase reactions |
JP2000342982A (en) | 1999-06-08 | 2000-12-12 | Applied Bio Systems Japan Kk | Fractional refiner for repeating type dispenser |
JP2006509994A (en) | 1999-07-26 | 2006-03-23 | ハーバード アパラタス インコーポレーティッド | Surface coated housing for sample preparation |
JP3425902B2 (en) | 1999-08-31 | 2003-07-14 | 株式会社日立製作所 | Sample pretreatment device |
US6325114B1 (en) | 2000-02-01 | 2001-12-04 | Incyte Genomics, Inc. | Pipetting station apparatus |
US7276158B1 (en) | 2000-06-09 | 2007-10-02 | Ashok K Shukla | Incision-based filtration/separation pipette tip |
WO2002040131A1 (en) | 2000-10-26 | 2002-05-23 | Ashok Kumar Shukla | Sample preparation device with embedded separation media |
US6782058B1 (en) | 2001-01-24 | 2004-08-24 | Advanced Micro Devices, Inc. | Device and method for interpolated signal resampling between sampling clock cycles |
CA2436136C (en) | 2001-01-26 | 2010-04-20 | Biocal Technology, Inc. | Multi-channel bio-separation cartridge |
US7157047B2 (en) | 2001-02-09 | 2007-01-02 | Pss Bio Instruments, Inc. | Device for containing, reacting and measuring, and method of containing, reacting and measuring |
RU2190846C1 (en) | 2001-04-19 | 2002-10-10 | Институт катализа им. Г.К.Борескова СО РАН | Chromatographic polycapillary column |
WO2003104814A2 (en) | 2002-01-01 | 2003-12-18 | Phynexus, Inc. | Biomolecule open channel solid phase extraction systems and methods |
JP3759910B2 (en) | 2002-02-28 | 2006-03-29 | 日東電工株式会社 | Chip filters and tips |
US7151167B2 (en) | 2002-06-10 | 2006-12-19 | Phynexus, Inc. | Open channel solid phase extraction systems and methods |
JP2004160368A (en) | 2002-11-13 | 2004-06-10 | Seiko Epson Corp | Liquid storage tank, droplet discharge unit, droplet discharge apparatus, and manufacturing method for tank |
JP4315366B2 (en) | 2003-02-03 | 2009-08-19 | 日東電工株式会社 | Chip filter and chip |
US20040224425A1 (en) | 2003-05-08 | 2004-11-11 | Gjerde Douglas T. | Biomolecule open channel solid phase extraction systems and methods |
US20050019951A1 (en) | 2003-07-14 | 2005-01-27 | Gjerde Douglas T. | Method and device for extracting an analyte |
US20070017870A1 (en) | 2003-09-30 | 2007-01-25 | Belov Yuri P | Multicapillary device for sample preparation |
US20050254995A1 (en) | 2004-05-12 | 2005-11-17 | Harvard Apparatus, Inc. | Devices and methods to immobilize analytes of interest |
US20050281710A1 (en) | 2004-06-21 | 2005-12-22 | Crabtree James H | Low thermal mass multiple tube capillary sampling array |
EP1821105B1 (en) | 2004-12-10 | 2018-09-26 | Universal Bio Research Co., Ltd. | Chip having biosubstance immobilization region hermetically sealed therein, biosubstance immobilization region treating apparatus and method of treatment |
CN101076732B (en) | 2004-12-10 | 2012-11-28 | 环球生物研究株式会社 | Biomaterial immobilization carrier enclosing chip, biomaterial immobilization carrier treating apparatus and method of treating therefor |
CA2599591C (en) | 2005-02-28 | 2013-01-08 | University Of Virginia Patent Foundation | Dna extraction using a photo-polymerized monolith in a capillary |
CN101268371B (en) | 2005-09-05 | 2013-06-12 | 环球生物研究株式会社 | Various substances supporter, various substances supporter processing apparatus, and method of mentioned processing |
JP4157924B2 (en) | 2006-03-20 | 2008-10-01 | 農工大ティー・エル・オー株式会社 | Glycated protein separation / detection device |
JP2008022735A (en) | 2006-07-19 | 2008-02-07 | Nsk Ltd | Tip for data import instrument |
EP2067019B1 (en) | 2006-09-20 | 2013-10-23 | ChromBA, Inc. | Multicapillary method for sample preparation |
-
2006
- 2006-09-20 US US11/524,426 patent/US20070017870A1/en not_active Abandoned
-
2011
- 2011-01-27 US US13/015,400 patent/US8980093B2/en active Active
Patent Citations (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3570673A (en) * | 1968-09-07 | 1971-03-16 | Jenaer Glaswerk Schott & Gen | Separation column for liquid chromatography |
US4045352A (en) * | 1973-05-23 | 1977-08-30 | California Institute Of Technology | Ion-exchange hollow fibers |
US4043905A (en) * | 1974-08-26 | 1977-08-23 | Indiana University Foundation | Chromatographic separation columns with selectively modified active surfaces and methods for their preparations |
US4214020A (en) * | 1977-11-17 | 1980-07-22 | Monsanto Company | Processes for coating bundles of hollow fiber membranes |
US4293415A (en) * | 1979-04-27 | 1981-10-06 | Hewlett-Packard Company | Silica chromatographic column |
US4293413A (en) * | 1979-12-28 | 1981-10-06 | Baxter Travenol Laboratories, Inc. | Dialyzer blood circuit and bubble traps |
US4424127A (en) * | 1980-03-07 | 1984-01-03 | Johan Roeraade | Column for liquid and gas chromatography |
US4689267A (en) * | 1984-07-26 | 1987-08-25 | Shin-Etsu Chemical Co., Ltd. | Composite hollow fiber |
US4654265A (en) * | 1985-06-05 | 1987-03-31 | Ube Industries, Ltd. | Porous hollow fiber |
US4657742A (en) * | 1985-07-01 | 1987-04-14 | Ppg Industries, Inc. | Packed fiber glass reaction vessel |
US5154822A (en) * | 1986-07-28 | 1992-10-13 | 3I Research Exploitation Limited | Bonded chromatographic stationary phase |
US4999164A (en) * | 1986-10-20 | 1991-03-12 | Eppendorf-Netheler-Hinz Gmbh | Pipetting device comprising a retaining cone for holding a slip-on pipette tip and pipette tip for such pipetting device |
US4818264A (en) * | 1987-04-30 | 1989-04-04 | The Dow Chemical Company | Multicapillary gas chromatography column |
US5092155A (en) * | 1987-07-08 | 1992-03-03 | Thermedics Inc. | High speed detection of vapors of specific compounds |
US5092219A (en) * | 1987-07-08 | 1992-03-03 | Thermedics Inc. | Selective decomposition of nitrite esters and nitramines |
US4957620A (en) * | 1988-11-15 | 1990-09-18 | Hoechst Celanese Corporation | Liquid chromatography using microporous hollow fibers |
US5460781A (en) * | 1989-10-27 | 1995-10-24 | Fujirebio Kabushiki Kaisha | Hemoglobin sampler |
US5194333A (en) * | 1989-12-18 | 1993-03-16 | Tosoh Corporation | Packing material for reversed phase chromatography and process for its preparation |
US5395521A (en) * | 1991-05-31 | 1995-03-07 | Board Of Regents, The University Of Texas System | Automated column equilibration, column loading, column washing and column elution |
US5876918A (en) * | 1993-03-08 | 1999-03-02 | Hydros, Inc. | Aligned fiber diagnostic chromatography with positive and negative controls |
US5616701A (en) * | 1993-09-27 | 1997-04-01 | Becton Dickinson And Company | DNA purification by solid phase extraction using a hydroxide-washed glass fiber membrane |
US5438127A (en) * | 1993-09-27 | 1995-08-01 | Becton Dickinson And Company | DNA purification by solid phase extraction using a PCl3 modified glass fiber membrane |
US5610290A (en) * | 1993-09-27 | 1997-03-11 | Becton Dickinson And Company | DNA purification by solid phase extraction using glass fiber membrane previously treated with trifluoroacetic acid, and then with fluoride ion, hydroxide ion, or Bcl3 |
US6638482B1 (en) * | 1993-11-01 | 2003-10-28 | Nanogen, Inc. | Reconfigurable detection and analysis apparatus and method |
US5429746A (en) * | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
US5552047A (en) * | 1994-05-24 | 1996-09-03 | Terumo Kabushiki Kaisha | Hollow filament blood processing apparatus |
US6168948B1 (en) * | 1995-06-29 | 2001-01-02 | Affymetrix, Inc. | Miniaturized genetic analysis systems and methods |
US6117394A (en) * | 1996-04-10 | 2000-09-12 | Smith; James C. | Membrane filtered pipette tip |
US6306659B1 (en) * | 1996-06-28 | 2001-10-23 | Caliper Technologies Corp. | High throughput screening assay systems in microscale fluidic devices |
US5774779A (en) * | 1996-11-06 | 1998-06-30 | Materials And Electrochemical Research (Mer) Corporation | Multi-channel structures and processes for making such structures |
US6123905A (en) * | 1997-01-17 | 2000-09-26 | Matrix Technologies Corporation | Pipettor including an indicator and method of use |
US6048457A (en) * | 1997-02-26 | 2000-04-11 | Millipore Corporation | Cast membrane structures for sample preparation |
US6875354B1 (en) * | 1997-02-26 | 2005-04-05 | Millipore Corporation | Cast membrane structures for sample preparation |
US6635201B1 (en) * | 1997-02-26 | 2003-10-21 | Millipore Corporation | Cast membrane structures for sample preparation |
US6270674B1 (en) * | 1997-06-14 | 2001-08-07 | Akzo Nobel Nv | Membrane module with unilaterally embedded hollow fiber membranes |
US6794127B1 (en) * | 1997-06-16 | 2004-09-21 | Diversa Corporation | Capillary array-based sample screening |
US6866824B2 (en) * | 1997-06-16 | 2005-03-15 | Diversa Corporation | Capillary array-based sample screening |
US6174673B1 (en) * | 1997-06-16 | 2001-01-16 | Diversa Corporation | High throughput screening for novel enzymes |
US6045757A (en) * | 1997-06-30 | 2000-04-04 | Rainin Instrument Co., Inc. | Membrane filter pipette tip |
US6451260B1 (en) * | 1997-08-26 | 2002-09-17 | Dyax Corp. | Method for producing microporous elements, the microporous elements thus produced and uses thereof |
US6743633B1 (en) * | 1998-01-12 | 2004-06-01 | Massachusetts Institute Of Technology | Method for performing microassays |
US6387331B1 (en) * | 1998-01-12 | 2002-05-14 | Massachusetts Institute Of Technology | Method and apparatus for performing microassays |
US20040171166A1 (en) * | 1998-01-12 | 2004-09-02 | Massachusetts Institute Of Technology | Method and apparatus for performing microassays |
US6596237B1 (en) * | 1998-04-27 | 2003-07-22 | Nicholas F. Borrelli | Redrawn capillary imaging reservoir |
US6596545B1 (en) * | 1998-07-14 | 2003-07-22 | Zyomyx, Inc. | Microdevices for screening biomolecules |
US7247469B2 (en) * | 1998-07-14 | 2007-07-24 | Zyomyx, Inc. | Non-specific binding resistant protein arrays and methods for making the same |
US6576478B1 (en) * | 1998-07-14 | 2003-06-10 | Zyomyx, Inc. | Microdevices for high-throughput screening of biomolecules |
US6406921B1 (en) * | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
US6780582B1 (en) * | 1998-07-14 | 2004-08-24 | Zyomyx, Inc. | Arrays of protein-capture agents and methods of use thereof |
US6582969B1 (en) * | 1998-07-14 | 2003-06-24 | Zyomyx, Inc. | Microdevices for high-throughput screening of biomolecules |
US6886824B2 (en) * | 1998-08-25 | 2005-05-03 | Minolta Co., Ltd. | Binding member removing apparatus, automatic document feeder, sheet processing apparatus, and image forming apparatus |
US6357484B1 (en) * | 1998-08-31 | 2002-03-19 | Uop Llc | Microporous structure defined by a multiplicity of singular channels and method of making |
US6387236B2 (en) * | 1998-09-11 | 2002-05-14 | Pe Corporation (Ny) | Multi-channel capillary electrophoresis device including sheath-flow cuvette and replaceable capillary array |
US6231739B1 (en) * | 1998-09-11 | 2001-05-15 | The Perkin-Elmer Corporation | Multi-channel capillary electrophoresis device including sheath-flow cuvette and replacable capillary array |
US6759126B1 (en) * | 1998-09-21 | 2004-07-06 | University Of South Florida | Solid phase microextraction fiber structure and method of making |
US6338802B1 (en) * | 1998-10-29 | 2002-01-15 | Pe Corporation (Ny) | Multi-well microfiltration apparatus |
US6309828B1 (en) * | 1998-11-18 | 2001-10-30 | Agilent Technologies, Inc. | Method and apparatus for fabricating replicate arrays of nucleic acid molecules |
US6174352B1 (en) * | 1998-11-24 | 2001-01-16 | Uop Llc | Round profile multi-capillary assembly and method of making |
US20040038316A1 (en) * | 1999-05-10 | 2004-02-26 | Robert Kaiser | Cell separation device and methods for use |
US20040147042A1 (en) * | 1999-05-28 | 2004-07-29 | Miklos Gratzl | Device for precise chemical delivery and solution preparation |
US7521020B2 (en) * | 1999-05-28 | 2009-04-21 | Case Western Reserve University | Device for precise chemical delivery and solution preparation |
US7118657B2 (en) * | 1999-06-22 | 2006-10-10 | President And Fellows Of Harvard College | Pulsed ion beam control of solid state features |
US6207049B1 (en) * | 1999-07-30 | 2001-03-27 | Agilent Technologies, Inc. | Multichannel capillary column |
US6992181B2 (en) * | 1999-10-28 | 2006-01-31 | Gyros Ab | DNA isolation method |
US6566145B2 (en) * | 2000-02-09 | 2003-05-20 | William E Brewer | Disposable pipette extraction |
US20030173284A1 (en) * | 2000-05-13 | 2003-09-18 | Baker Matthew John | Separation device |
US6537502B1 (en) * | 2000-07-25 | 2003-03-25 | Harvard Apparatus, Inc. | Surface coated housing for sample preparation |
US20050003211A1 (en) * | 2000-09-05 | 2005-01-06 | Hitachi, Ltd. | Removal method for coating of polymer coated glass capillary tubing and polymer coated glass capillary tubing |
US6780314B2 (en) * | 2000-11-01 | 2004-08-24 | Shinwa Chemical Industries, Ltd. | Separation column for chromatography, medium for solid phase extraction and sample injection system for chromatography |
US7211189B2 (en) * | 2000-11-01 | 2007-05-01 | Shinwa Chemical Industries, Ltd. | Separation column from chromatography, medium for solid phase extraction and sample injection system for chromatography |
US20020110495A1 (en) * | 2001-01-05 | 2002-08-15 | Denis Hunt | Devices and methods for purification |
US6416716B1 (en) * | 2001-04-20 | 2002-07-09 | Ashok Kumar Shukla | Sample preparation device with embedded separation media |
US20030068317A1 (en) * | 2001-04-20 | 2003-04-10 | William Lee | High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon |
US20040191537A1 (en) * | 2001-06-13 | 2004-09-30 | Dieter Lubda | Restricted access material for spme |
US20030007897A1 (en) * | 2001-07-06 | 2003-01-09 | Andrew Creasey | Pipette tips |
US20070071649A1 (en) * | 2001-09-10 | 2007-03-29 | Marcus R Kenneth | Capillary-channeled polymer fibers as stationary phase media for spectroscopic analysis |
US6870165B2 (en) * | 2001-10-19 | 2005-03-22 | Biocal Technology, Inc. | Multi-color multiplexed analysis in a bio-separation system |
US7208072B2 (en) * | 2002-01-18 | 2007-04-24 | Biocal Technology, Inc. | Multi-segment cartridge for bio-separation with multiplexed fluorescence detection |
US7122640B2 (en) * | 2002-06-10 | 2006-10-17 | Phynexus, Inc. | Open channel solid phase extraction systems and methods |
US20060062701A1 (en) * | 2002-07-18 | 2006-03-23 | Hiroyuki Nakamura | Method of manufacturing microwave reaction device and microwave reaction device |
US7118671B2 (en) * | 2003-04-30 | 2006-10-10 | Institute For Roentgen Optics | Polycapillary chromatographic column and method of its manufacturing |
US20060216206A1 (en) * | 2003-05-29 | 2006-09-28 | Hudson William C | Solid phase extraction pipette |
US7595026B2 (en) * | 2003-05-29 | 2009-09-29 | Varian, Inc. | Solid phase extraction pipette |
US20050139536A1 (en) * | 2003-09-30 | 2005-06-30 | Belov Yuri P. | Multicapillary column for chromatography and sample preparation |
US20070075007A1 (en) * | 2003-09-30 | 2007-04-05 | Belov Yuri P | Multicapillary column for chromatography and sample preparation |
US7964097B2 (en) * | 2003-09-30 | 2011-06-21 | Belov Yuri P | Multicapillary column for chromatography and sample preparation |
US7166212B2 (en) * | 2003-09-30 | 2007-01-23 | Chromba, Inc. | Multicapillary column for chromatography and sample preparation |
US20070111194A1 (en) * | 2003-12-15 | 2007-05-17 | Preentec Ag | Method for the concentration and purification of biological compounds |
US20050178709A1 (en) * | 2004-01-23 | 2005-08-18 | Ngk Insulators, Ltd. | Supports for solid phase extraction |
US7271895B2 (en) * | 2004-04-09 | 2007-09-18 | Institute For Roentgen Optics | Fluorescent sensor on basis of multichannel structures |
US20060201881A1 (en) * | 2004-08-10 | 2006-09-14 | Clemson University | Capillary-channeled polymeric fiber as solid phase extraction media |
US20060093518A1 (en) * | 2004-10-29 | 2006-05-04 | Shukla Ashok K | Device containing non-covalently bound biomolecules on solid support |
US20060118491A1 (en) * | 2004-12-03 | 2006-06-08 | Gjerde Douglas T | Method and device for desalting an analyte |
US20070116607A1 (en) * | 2005-11-23 | 2007-05-24 | Pharmacom Microlelectronics, Inc. | Microsystems that integrate three-dimensional microarray and multi-layer microfluidics for combinatorial detection of bioagent at single molecule level |
US20070215543A1 (en) * | 2006-03-14 | 2007-09-20 | Mettler-Toledo Autochem, Inc. | Small volume liquid-liquid extraction device and method of use |
US7759112B2 (en) * | 2007-10-31 | 2010-07-20 | Akonni Biosystems, Inc. | Apparatus, system, and method for purifying nucleic acids |
US20110092686A1 (en) * | 2008-03-28 | 2011-04-21 | Pelican Group Holdings, Inc. | Multicapillary sample preparation devices and methods for processing analytes |
US20110107855A1 (en) * | 2008-03-28 | 2011-05-12 | Pelican Group Holdings, Inc. | Sample preparation devices and methods for processing analytes |
Cited By (115)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070075007A1 (en) * | 2003-09-30 | 2007-04-05 | Belov Yuri P | Multicapillary column for chromatography and sample preparation |
US20110210057A1 (en) * | 2003-09-30 | 2011-09-01 | Belov Yuri P | Multicapillary column for chromatography and sample preparation |
US8980093B2 (en) | 2003-09-30 | 2015-03-17 | Yuri P. Belov | Multicapillary device for sample preparation |
US7964097B2 (en) | 2003-09-30 | 2011-06-21 | Belov Yuri P | Multicapillary column for chromatography and sample preparation |
US20050186685A1 (en) * | 2004-01-17 | 2005-08-25 | Gyros Ab | Protecting agent |
US8592219B2 (en) * | 2005-01-17 | 2013-11-26 | Gyros Patent Ab | Protecting agent |
US20080233594A1 (en) * | 2005-01-17 | 2008-09-25 | Gyros Patent Ab | Method For Detecting An At Least Bivalent Analyte Using Two Affinity Reactants |
US20100155242A1 (en) * | 2006-09-04 | 2010-06-24 | Arkray, Inc. | Method of Analyzing a Sample by Capillary Electrophoresis |
US20100187110A1 (en) * | 2006-09-04 | 2010-07-29 | National Institute Of Advanced Industrial Science And Technology | Process for analyzing sample by capillary electrophoresis method |
US20100175996A1 (en) * | 2006-09-04 | 2010-07-15 | Arkray, Inc. | Process for analyzing sample by capillary electrophoresis method |
US9121821B2 (en) | 2006-09-04 | 2015-09-01 | National Institute Of Advanced Industrial Science And Technology | Process for analyzing sample by capillary electrophoresis method |
US8137512B2 (en) * | 2006-09-04 | 2012-03-20 | National Institute Of Advanced Industrial Science And Technology | Process for analyzing sample by capillary electrophoresis method |
US20090200166A1 (en) * | 2008-02-08 | 2009-08-13 | Arkray, Inc. | Method of Analyzing Hemoglobin by Capillary Eletrophoresis |
US20110092686A1 (en) * | 2008-03-28 | 2011-04-21 | Pelican Group Holdings, Inc. | Multicapillary sample preparation devices and methods for processing analytes |
EP3459635A1 (en) | 2008-04-11 | 2019-03-27 | Biotix, Inc. | Pipette tip handling devices and methods |
US20090255949A1 (en) * | 2008-04-11 | 2009-10-15 | Pelican Group Holdings, Inc. | Pipette tip handling devices and methods |
US20100089938A1 (en) * | 2008-04-11 | 2010-04-15 | Arta Motadel | Pipette tip handling devices and methods |
US9238227B2 (en) | 2008-04-11 | 2016-01-19 | Biotix, Inc. | Pipette tip handling devices and methods |
US9505006B2 (en) | 2008-04-11 | 2016-11-29 | Biotix, Inc. | Pipette tip handling devices and methods |
US8460622B2 (en) | 2008-04-11 | 2013-06-11 | Biotix, Inc. | Pipette tip handling devices and methods |
US20100218622A1 (en) * | 2009-01-12 | 2010-09-02 | Biotix, Inc. | Flexible pipette tips |
US8307721B2 (en) | 2009-01-12 | 2012-11-13 | Biotix, Inc. | Flexible pipette tips |
US20100219093A1 (en) * | 2009-01-13 | 2010-09-02 | Biotix, Inc. | Manufacture processes for assessing pipette tip quality |
US9039971B2 (en) | 2009-01-13 | 2015-05-26 | Biotix, Inc | Manufacture processes for assessing pipette tip quality |
US9878330B2 (en) | 2009-01-23 | 2018-01-30 | Biotix, Inc. | Anti-static pipette tip trays |
US8470265B2 (en) | 2009-01-23 | 2013-06-25 | Biotix, Inc. | Anti-static pipette tip trays |
US20100221151A1 (en) * | 2009-01-23 | 2010-09-02 | Biotix, Inc. | Anti-static pipette tip trays |
US10300488B2 (en) | 2009-01-23 | 2019-05-28 | Biotix, Inc. | Anti-static pipette tip trays |
US9089845B2 (en) | 2009-01-23 | 2015-07-28 | Biotix, Inc. | Anti-static pipette tip trays |
US8590736B2 (en) | 2009-04-11 | 2013-11-26 | Biotix, Inc. | Automated pipette tip loading devices and methods |
USD697227S1 (en) | 2009-04-11 | 2014-01-07 | Biotix, Inc. | Pipette tip handling device set |
US20100258578A1 (en) * | 2009-04-11 | 2010-10-14 | Biotix, Inc. | Automated pipette tip loading devices and methods |
US8834954B2 (en) | 2009-05-13 | 2014-09-16 | Sio2 Medical Products, Inc. | Vessel inspection apparatus and methods |
US7985188B2 (en) | 2009-05-13 | 2011-07-26 | Cv Holdings Llc | Vessel, coating, inspection and processing apparatus |
US10537273B2 (en) | 2009-05-13 | 2020-01-21 | Sio2 Medical Products, Inc. | Syringe with PECVD lubricity layer |
US8512796B2 (en) | 2009-05-13 | 2013-08-20 | Si02 Medical Products, Inc. | Vessel inspection apparatus and methods |
US10390744B2 (en) | 2009-05-13 | 2019-08-27 | Sio2 Medical Products, Inc. | Syringe with PECVD lubricity layer, apparatus and method for transporting a vessel to and from a PECVD processing station, and double wall plastic vessel |
US9572526B2 (en) | 2009-05-13 | 2017-02-21 | Sio2 Medical Products, Inc. | Apparatus and method for transporting a vessel to and from a PECVD processing station |
US9545360B2 (en) | 2009-05-13 | 2017-01-17 | Sio2 Medical Products, Inc. | Saccharide protective coating for pharmaceutical package |
US9458536B2 (en) | 2009-07-02 | 2016-10-04 | Sio2 Medical Products, Inc. | PECVD coating methods for capped syringes, cartridges and other articles |
US20110165327A1 (en) * | 2010-01-01 | 2011-07-07 | Samsung Mobile Display Co., Ltd. | Thin film deposition apparatus |
US10828633B2 (en) | 2010-01-22 | 2020-11-10 | Biotix, Inc. | Pipette tips |
US9486803B2 (en) | 2010-01-22 | 2016-11-08 | Biotix, Inc. | Pipette tips |
US20110183433A1 (en) * | 2010-01-22 | 2011-07-28 | Biotix, Inc. | Pipette tips |
EP3831489A1 (en) | 2010-01-22 | 2021-06-09 | Biotix, Inc. | Pipette tips |
US11590490B2 (en) | 2010-01-22 | 2023-02-28 | Biotix, Inc. | Pipette tips |
US9636672B2 (en) | 2010-01-22 | 2017-05-02 | Biotix, Inc. | Pipette tips |
US10307753B2 (en) | 2010-01-22 | 2019-06-04 | Biotix, Inc. | Pipette tips |
US9101923B2 (en) | 2010-01-22 | 2015-08-11 | Biotix, Inc. | Pipette tips |
US11624115B2 (en) | 2010-05-12 | 2023-04-11 | Sio2 Medical Products, Inc. | Syringe with PECVD lubrication |
US11123491B2 (en) | 2010-11-12 | 2021-09-21 | Sio2 Medical Products, Inc. | Cyclic olefin polymer vessels and vessel coating methods |
US9878101B2 (en) | 2010-11-12 | 2018-01-30 | Sio2 Medical Products, Inc. | Cyclic olefin polymer vessels and vessel coating methods |
US9272095B2 (en) | 2011-04-01 | 2016-03-01 | Sio2 Medical Products, Inc. | Vessels, contact surfaces, and coating and inspection apparatus and methods |
US11148856B2 (en) | 2011-11-11 | 2021-10-19 | Sio2 Medical Products, Inc. | Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus |
US10577154B2 (en) | 2011-11-11 | 2020-03-03 | Sio2 Medical Products, Inc. | Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus |
US11884446B2 (en) | 2011-11-11 | 2024-01-30 | Sio2 Medical Products, Inc. | Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus |
US11116695B2 (en) | 2011-11-11 | 2021-09-14 | Sio2 Medical Products, Inc. | Blood sample collection tube |
US10189603B2 (en) | 2011-11-11 | 2019-01-29 | Sio2 Medical Products, Inc. | Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus |
US11724860B2 (en) | 2011-11-11 | 2023-08-15 | Sio2 Medical Products, Inc. | Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus |
US10654037B2 (en) | 2012-05-30 | 2020-05-19 | Biotix, Inc. | Integrated pipette tip devices |
US9302262B2 (en) | 2012-05-30 | 2016-04-05 | Biotix, Inc. | Integrated pipette tip devices |
US9597680B2 (en) | 2012-05-30 | 2017-03-21 | Biotix, Inc. | Integrated pipette tip devices |
US8795606B2 (en) | 2012-05-30 | 2014-08-05 | Biotix, Inc. | Integrated pipette tip devices |
US11433389B2 (en) | 2012-05-30 | 2022-09-06 | Biotix, Inc. | Integrated pipette tip devices |
US9884319B2 (en) | 2012-05-30 | 2018-02-06 | Biotix, Inc. | Integrated pipette tip devices |
US9664626B2 (en) | 2012-11-01 | 2017-05-30 | Sio2 Medical Products, Inc. | Coating inspection method |
US9903782B2 (en) | 2012-11-16 | 2018-02-27 | Sio2 Medical Products, Inc. | Method and apparatus for detecting rapid barrier coating integrity characteristics |
US10363370B2 (en) | 2012-11-30 | 2019-07-30 | Sio2 Medical Products, Inc. | Controlling the uniformity of PECVD deposition |
US11406765B2 (en) | 2012-11-30 | 2022-08-09 | Sio2 Medical Products, Inc. | Controlling the uniformity of PECVD deposition |
US10201660B2 (en) | 2012-11-30 | 2019-02-12 | Sio2 Medical Products, Inc. | Controlling the uniformity of PECVD deposition on medical syringes, cartridges, and the like |
US9764093B2 (en) | 2012-11-30 | 2017-09-19 | Sio2 Medical Products, Inc. | Controlling the uniformity of PECVD deposition |
US9662450B2 (en) | 2013-03-01 | 2017-05-30 | Sio2 Medical Products, Inc. | Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus |
US11298293B2 (en) | 2013-03-11 | 2022-04-12 | Sio2 Medical Products, Inc. | PECVD coated pharmaceutical packaging |
US10912714B2 (en) | 2013-03-11 | 2021-02-09 | Sio2 Medical Products, Inc. | PECVD coated pharmaceutical packaging |
US9554968B2 (en) | 2013-03-11 | 2017-01-31 | Sio2 Medical Products, Inc. | Trilayer coated pharmaceutical packaging |
US11684546B2 (en) | 2013-03-11 | 2023-06-27 | Sio2 Medical Products, Inc. | PECVD coated pharmaceutical packaging |
US9937099B2 (en) | 2013-03-11 | 2018-04-10 | Sio2 Medical Products, Inc. | Trilayer coated pharmaceutical packaging with low oxygen transmission rate |
US11344473B2 (en) | 2013-03-11 | 2022-05-31 | SiO2Medical Products, Inc. | Coated packaging |
US10016338B2 (en) | 2013-03-11 | 2018-07-10 | Sio2 Medical Products, Inc. | Trilayer coated pharmaceutical packaging |
US10537494B2 (en) | 2013-03-11 | 2020-01-21 | Sio2 Medical Products, Inc. | Trilayer coated blood collection tube with low oxygen transmission rate |
USD787698S1 (en) | 2013-03-15 | 2017-05-23 | Nalge Nunc International Corporation | Pipette |
US9863042B2 (en) | 2013-03-15 | 2018-01-09 | Sio2 Medical Products, Inc. | PECVD lubricity vessel coating, coating process and apparatus providing different power levels in two phases |
USD731075S1 (en) * | 2013-03-15 | 2015-06-02 | Nalge Nunc International Corporation | Pipette |
US10343156B2 (en) | 2013-03-15 | 2019-07-09 | Nalge Nunc International Corporation | Tapered pipette |
RU2547597C1 (en) * | 2013-09-27 | 2015-04-10 | Юлия Сергеевна Скибина | Multi-channel nozzle for extraction of nucleic acids, proteins and peptides |
US20150279648A1 (en) * | 2014-03-26 | 2015-10-01 | Li-Cor, Inc. | Laser desorption ionization mass spectrometry using a particulate separation bed |
US9595430B2 (en) * | 2014-03-26 | 2017-03-14 | Li-Cor, Inc. | Laser desorption ionization mass spectrometry using a particulate separation bed |
US11066745B2 (en) | 2014-03-28 | 2021-07-20 | Sio2 Medical Products, Inc. | Antistatic coatings for plastic vessels |
US10864461B2 (en) | 2014-09-29 | 2020-12-15 | Francois Parmentier | Organic gel or liquid chromatography method |
WO2016050789A1 (en) * | 2014-09-29 | 2016-04-07 | François Parmentier | Organic gel or liquid chromatography method |
JP2017530375A (en) * | 2014-09-29 | 2017-10-12 | パルマンティエ、フランソワ | Organic gel or liquid chromatography method |
FR3026312A1 (en) * | 2014-09-29 | 2016-04-01 | Francois Parmentier | PROCESS FOR CHROMATOGRAPHY ON A GEL OR ORGANIC LIQUID |
US10137453B2 (en) | 2014-12-10 | 2018-11-27 | Biotix, Inc. | Static-defeating apparatus for pipette tips |
USD849962S1 (en) | 2014-12-10 | 2019-05-28 | Biotix, Inc. | Pipette tip retention sheet |
US10730053B2 (en) | 2014-12-10 | 2020-08-04 | Biotix, Inc. | Static-defeating apparatus for pipette tips |
USD815753S1 (en) | 2014-12-10 | 2018-04-17 | Biotix, Inc. | Pipette tip sheet |
USD922610S1 (en) | 2014-12-10 | 2021-06-15 | Biotix, Inc. | Pipette tip sheet assembly |
USD875968S1 (en) | 2014-12-10 | 2020-02-18 | Biotix, Inc. | Pipette tip sheet assembly |
USD905272S1 (en) | 2014-12-10 | 2020-12-15 | Biotix, Inc. | Pipette tip retention sheet assembly |
USD824535S1 (en) | 2014-12-10 | 2018-07-31 | Biotix, Inc. | Pipette tip sheet |
USD833031S1 (en) | 2014-12-10 | 2018-11-06 | Biotix, Inc. | Pipette tip sheet |
USD865216S1 (en) | 2014-12-10 | 2019-10-29 | Biotix, Inc. | Pipette tip sheet |
USD956999S1 (en) | 2014-12-10 | 2022-07-05 | Biotix, Inc. | Pipette tip sheet assembly |
US11040351B2 (en) | 2014-12-10 | 2021-06-22 | Biotix, Inc. | Method for dispensing fluid |
US10258992B2 (en) | 2014-12-10 | 2019-04-16 | Biotix, Inc. | Static-defeating apparatus for pipette tips |
US11077233B2 (en) | 2015-08-18 | 2021-08-03 | Sio2 Medical Products, Inc. | Pharmaceutical and other packaging with low oxygen transmission rate |
US10946374B2 (en) | 2017-05-17 | 2021-03-16 | Biotix, Inc. | Ergonomic pipette tips |
USD983401S1 (en) | 2018-05-11 | 2023-04-11 | Biotix, Inc. | Pipette tip |
USD905865S1 (en) | 2018-05-11 | 2020-12-22 | Biotix, Inc. | Pipette tip |
USD983399S1 (en) | 2018-05-11 | 2023-04-11 | Biotix, Inc. | Pipette tip |
USD983397S1 (en) | 2018-05-11 | 2023-04-11 | Biotix, Inc. | Pipette tip |
USD983400S1 (en) | 2018-05-11 | 2023-04-11 | Biotix, Inc. | Pipette tip |
USD983398S1 (en) | 2018-05-11 | 2023-04-11 | Biotix, Inc. | Pipette tip |
WO2019217098A1 (en) | 2018-05-11 | 2019-11-14 | Biotix, Inc. | Pipette tip |
US11185856B2 (en) | 2018-05-11 | 2021-11-30 | Biotix, Inc. | Pipette tip |
Also Published As
Publication number | Publication date |
---|---|
US8980093B2 (en) | 2015-03-17 |
US20110263838A1 (en) | 2011-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8980093B2 (en) | Multicapillary device for sample preparation | |
US6723236B2 (en) | Device for solid phase extraction and method for purifying samples prior to analysis | |
Gilar et al. | Advances in sample preparation in electromigration, chromatographic and mass spectrometric separation methods | |
US6416716B1 (en) | Sample preparation device with embedded separation media | |
JP5524059B2 (en) | Isolation method of functional polymer | |
US8053247B2 (en) | Method and device for preparing an analyte for analysis by mass spectrometry | |
US7740763B2 (en) | Capillary-channeled polymeric fiber as solid phase extraction media | |
US9592500B2 (en) | Filtration and extraction assembly | |
EP2067019B1 (en) | Multicapillary method for sample preparation | |
US20080093548A1 (en) | Sample preparation plate for mass spectrometry | |
US7276158B1 (en) | Incision-based filtration/separation pipette tip | |
US20090023897A1 (en) | Method and apparatus for purifying and desalting biological samples | |
JP2023133382A (en) | Systems and methods for analyzing analyte extracted from sample using adsorbent material | |
US20160252516A1 (en) | System and method for high throughput mass spectrometric analysis of proteome samples | |
JP2006509994A (en) | Surface coated housing for sample preparation | |
EP2503330A2 (en) | Multicapillary device for sample preparation | |
JP2005513472A (en) | Analyzer and analysis method | |
AU2014202027A1 (en) | Multicapillary device for sample preparation | |
JP2012123014A (en) | Multiple capillary device for sample preparation | |
WO2002040131A1 (en) | Sample preparation device with embedded separation media | |
Vas et al. | Biomedical sampling | |
Huck et al. | Sample preparation techniques for mass spectrometry in proteomics using recently developed highly selective materials | |
CN113767286A (en) | Method for improving detection of glycosylamines | |
RU2100045C1 (en) | Method of concentrating organic compounds from water | |
Fornea | Incorporation of capillary-channeled polymer (C-CP) fibers into micropipette tips for solid phase extraction with applications in bioanalysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CHROMBA, INC., PENNSYLVANIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BELOV, YURI P.;PANTANO, CARLO G.;LVOVA, KSENIA;REEL/FRAME:018422/0700;SIGNING DATES FROM 20060913 TO 20060918 |
|
AS | Assignment |
Owner name: BIOEDGE, LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CHROMBA, INC.;REEL/FRAME:021524/0858 Effective date: 20080912 |
|
AS | Assignment |
Owner name: BIOEDGE, LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MOTADEL, ARTA;REEL/FRAME:021596/0671 Effective date: 20080926 |
|
AS | Assignment |
Owner name: BIOTIX, CALIFORNIA Free format text: LICENSE;ASSIGNOR:CHROMBA;REEL/FRAME:021599/0685 Effective date: 20070110 |
|
AS | Assignment |
Owner name: BIOEDGE, LLC, CALIFORNIA Free format text: LICENSE;ASSIGNOR:CHROMBA, INC.;REEL/FRAME:021632/0812 Effective date: 20080101 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE |